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Abstract 
Staphylococcus aureus must rapidly adapt to a variety of carbon and nitrogen sources 
during invasion of a host. Within a staphylococcal abscess, preferred carbon sources 
such as glucose are limiting, suggesting S. aureus survives through the catabolism of 
secondary carbon sources. S. aureus encodes pathways to catabolize multiple amino 
acids including those that generate pyruvate, 2-oxoglutarate, and oxaloacetate. To 
assess amino acid catabolism, S. aureus JE2 and mutants were grown in complete 
defined medium containing 18 amino acids but lacking glucose (CDM). A mutation in 
glutamate dehydrogenase (gudB), which generates 2-oxoglutarate from glutamate, 
abrogated growth in CDM suggesting that glutamate and those amino acids generating 
glutamate, particularly proline, serve as the major carbon source in this media. Nuclear 
Magnetic Resonance (NMR) studies confirmed this hypothesis. Furthermore, a mutation 
in acetate kinase (ackA) also abrogated growth of JE2 in CDM suggesting that ATP 
production from pyruvate-producing amino acids is also critical for growth. In addition, 
although a functional respiratory chain was absolutely required for growth, the relative 
oxygen consumption rate and intracellular ATP concentration were significantly lower 
during growth in CDM when compared to growth in glucose-containing media. Finally, 
transcriptional analyses demonstrated that genes coding for the enzymes that 
synthesize glutamate from proline, arginine and histidine are repressed by CcpA and 
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carbon catabolite repression. We also demonstrated that in the absence of CcpA 
repression, the global transcriptional regulator, CodY, functions to positively regulate 
proline catabolism by activating putA expression.  The arginine transcriptional regulator, 
ArgR1, also functions to positively regulate putA expression, while the arginine 
transcriptional regulators, ArgR2 and AhrC, are functioning to repress arginine 
biosynthesis via argG; presumably in the presence of arginine.  These data demonstrate 
that pathways important for glutamate catabolism and ATP generation via Pta/AckA are 
important for growth in niches where glucose is not abundant. 
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Metabolism is central to microbial life, as all bacteria require carbon and 
energy for growth and replication.  While lifestyles and specific niches occupied 
by organisms vary, the fundamental metabolic tasks are similar across divergent 
species of bacteria.  All organisms must regulate the uptake of nutrients and 
coordinate energy, carbon, and nitrogen metabolism to sustain cell maintenance 
and growth (1, 2).   
Pathogenic bacteria such as Staphylococcus aureus transiently derive 
their carbon and energy sources through destruction of host tissue via the 
synthesis of a wide assortment of virulence factors (1).  The specific carbon and 
nitrogen sources available during host invasion are unclear as S. aureus has the 
ability to establish an infection in a wide variety of niches within the human host, 
including the heart, bone, kidney, blood, and soft tissue.  Recent studies have 
demonstrated that S. aureus adapts to the changing carbon sources and oxygen 
availability found within specific organ systems.  For example, S. aureus 
defective in anaerobic fermentation were less virulent than wild type in a mouse 
model of kidney infection (3), while mutants defective in aerobic respiration were 
unable to mediate infection in the heart or liver.  However, kidney colonization 
and subsequent abscess formation was unaffected in the mutants defective in 
aerobic respiration (4).  Furthermore, mutants defective in CcpA, the global 
carbon catabolite repressor, are less effective at infecting the liver where glucose 
is abundant, but colonization in the kidney is not affected (5).  Collectively, these 
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data suggest that S. aureus uses distinct metabolic pathways to adapt to nutrient 
availability and environmental changes within specific host niches.     
S. aureus lacks the ability to utilize phospholipids, triglycerides, and 
potentially other short chain fatty acids as carbon due to the lack of a β-oxidation 
system and glyoxylate shunt pathway.  However, it has been presumed S. 
aureus has the ability to utilize peptides/amino acids as carbon sources as it 
encodes multiple oligopeptide permeases and free amino acid transporters, as 
well as proteases that have the ability to degrade host proteins (6-9).  
Bioinformatics analysis suggests that pathways are present to catabolize multiple 
amino acids including those that generate the central metabolic intermediates 
pyruvate, 2-oxoglutarate, and oxaloacetate (Table 1, Figure 1.1).  Taken 
together, these data suggest S. aureus encounters environments within the host 
where peptides and free amino acids may be abundant carbon sources, fueling 
growth.  
Recent work from Spahich and colleagues found that the addition of 
lactate plus peptides support growth of S. aureus under moderate nitric oxide 
(NO) stress (10).  These studies demonstrated that lactate quinone 
oxidoreductase (Lqo) assimilates the lactate excreted during the fermentation of 
glucose as a result of NO stress. Lqo generates pyruvate and subsequently 
acetate via Pta/AckA in an NAD-independent manner and requires an electron 
acceptor such as oxygen or nitrate (11).  Peptides are required under these 
conditions to serve as a carbon backbone to facilitate gluconeogenesis, 
suggesting a requirement for amino acid catabolism during pathogenesis.  
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Figure 1.1.  Amino acid catabolic pathways in B. subtilis and S. aureus. 
Genes in blue are encoded by B. subtilis.  Genes in black are encoded by B. 
subtilis and S. aureus. Genes in red are encoded by S. aureus. 
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Amino acid catabolism  
Bacteria take advantage of a wide range of nutrient sources available 
within specific environments.  The human body is a reservoir of nutrients for 
pathogenic bacteria, which can be divided into numerous microenvironments.  
Extracellular bacterial pathogens often face environments with frequently 
changing nutrients; therefore, they must be able to scavenge those available 
nutrient sources to fuel central metabolic pathways for generation of energy and 
macromolecule production (12, 13).   
Amino acids are essential building blocks for protein synthesis in all living 
organisms.  In many bacteria, the conversion of peptides to free amino acids and 
the subsequent utilization of those amino acids in central metabolic pathways is 
essential for growth and survival.  The hydrolysis of exogenous peptides via 
peptidases allows for free amino acids to be utilized in processes such as protein 
synthesis, generation of energy, and carbon metabolism (14).  Evidence 
suggests that amino acid catabolism in anaerobic and fermentative bacteria is 
important for obtaining energy in nutrient-limiting environments.  For example, in 
several species of lactic acid bacteria, arginine catabolized via the arginine 
deiminase pathway (ADI) provides energy for growth via substrate-level 
phosphorylation (15, 16).  Furthermore, it has been known since the 1930’s that 
in several nonpathogenic Clostridium species, amino acid metabolism via 
Stickland fermentation is a primary source of energy when the bacteria are grown 
with amino acids as sole sources of carbon and nitrogen (17-20).   Stickland 
fermentation couples the oxidation of one amino acid (typically alanine, valine, 
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leucine, serine, isoleucine, or threonine) to the reduction of another (typically 
glycine, proline, or aspartic acid), resulting in organic acid production, redox 
balance, and ATP synthesis via substrate-level phosphorylation (Figure 1.2; (21, 
22).  Recent work from Bouillaut and colleagues demonstrated that Stickland 
fermentation of proline in the pathogenic Clostridium difficile is required for 
optimal growth, even in rich media with abundant carbon sources (22).  Taken 
together, these data provide evidence of the importance of amino acid utilization 
in central metabolism in several bacterial species.        
To date little is known about S. aureus amino acid catabolism.  As 
previously mentioned, bioinformatics analysis predicts S. aureus has the ability to 
catabolize amino acids into three central metabolic intermediates (Table 1).  The 
glucogenic amino acids alanine, serine, glycine, threonine, and cysteine can 
serve as precursors for the synthesis of pyruvate, while aspartate and 
asparagine are substrates for the TCA cycle intermediate, oxaloacetate.  
Furthermore, glutamate, glutamine, histidine, arginine, and proline can serve as 
precursors for 2-oxoglutarate synthesis.  Genes for complete catabolic pathways 
were not identified for tryptophan, isoleucine, leucine, lysine, methionine, 
phenylalanine, tyrosine, and valine.   The following sections will describe the 
current knowledge of amino acid catabolic pathways in B. subtilis and how these 
pathways may be involved in S. aureus amino acid catabolism.  Figure 1.1 is an 





Figure 1.2.  Stickland Fermentation.  Oxidation (A) and reduction (B) of pairs of 
amino acids.  The recycling of the electrons and protons facilitates redox balance 
while generating ATP.	
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2-oxoglutarate generating amino acids:  
The TCA cycle intermediate, 2-oxoglutarate, is positioned at the 
intersection of carbon and nitrogen metabolism.  It can be utilized in carbon 
metabolism and energy generation via the TCA cycle, while also acting as the 
major carbon skeleton for nitrogen-assimilatory reactions through its conversion 
to glutamate via glutamate synthase (GOGAT).  Intracellular 2-oxoglutarate may 
serve as an indicator to the cell of the available carbon supply, as it has been 
demonstrated that with the addition of glucose, there is a quick and significant 
increase in intracellular 2-oxoglutarate (23).  In B. subtilis, GOGAT expression is 
induced in the presence of 2-oxoglutarate, while being suppressed by high 
glutamate concentrations.  Thus, the 2-oxoglutarate/glutamate ratio is regulating 
nitrogen assimilation (24).  Glutamate and those amino acids that serve as 
substrates for glutamate (proline, arginine, and histidine) can fuel 2-oxoglutarate 
synthesis via the enzyme glutamate dehydrogenase in the absence of CcpA 
repression (23, 25). 
Glutamate.   
Glutamate and glutamine serve as the major amino group donors for all 
nitrogen-containing compounds, with glutamate providing 80-88% of the nitrogen 
in nitrogenous compounds.  In Escherichia coli, glutamate is the most abundant 
metabolite in the cell, accounting for 40% of the metabolite concentration (26).  
Glutamate is synthesized exclusively in B. subtilis from the carbon backbone of 
2-oxoglutarate via glutamate synthase (GOGAT) and can also be degraded into 
2-oxoglutarate directly via glutamate dehydrogenase, thus linking carbon and 
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nitrogen metabolism (12, 27).  B. subtilis encodes two glutamate 
dehydrogenases via the rocG and gudB genes.  However, in most laboratory 
strains of B. subtilis only RocG is enzymatically active (25, 28).  GudB is inactive 
due to a 9 bp direct repeat, causing a duplication of three amino acids in the 
active center of the enzyme (29).  Interestingly, inactivation of rocG causes 
spontaneous mutations to occur in GudB, resulting in enzymatic activity (28).  In 
S. aureus, only gudB is present and currently is not well characterized.   
In B. subtilis, rocG is subject to regulatory signals from both carbon and 
nitrogen metabolism.  In the presence of glucose, CcpA strongly represses rocG 
transcription through its interaction with the rocG promoter (28, 30). The rocG 
gene is induced by the transcription factors AhrC and RocR in presence of 
arginine, ornithine, and/or proline, allowing for the use of these compounds as 
carbon and nitrogen sources (31-33).  The alternative sigma factor, σL, is also 
required for transcription of rocG.  Interestingly, σL is also strongly repressed by 
CcpA in the presence of glucose (34, 35).  These layers of regulation, which are 
dependent on the carbon and nitrogen sources available, ensure that an active 
RocG is only present when the degradation of glutamate to 2-oxoglutarate is 
required.  
B. subtilis also utilizes glutamate as a substrate for both proline and 
arginine synthesis.  Proline can be synthesized via three enzymatic reactions 
carried out by γ-glutamate kinase (ProB/ProJ), γ glutamyl-phosphate reductase 
(ProA), and Δ1-pyrroline-5-carboxylate (P5C) reductase (ProI/ProH/ProG) (36).  
However, S. aureus does not encode orthologus genes for this pathway and 
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apparently cannot synthesize proline from glutamate.  The absence of proline 
synthesis via glutamate has been demonstrated by studies showing S. aureus 
grown in the presence of radiolabeled glutamate does not result in the generation 
of radiolabelled proline (37).   
B. subtilis, among several other bacterial species, also utilizes glutamate 
as a substrate for arginine synthesis via the highly conserved argJBCDFGH 
operon.  In this pathway, glutamate is catabolized in five enzymatic steps to 
ornithine, which is then further catabolized into arginine via the urea cycle (38).  
However, S. aureus is an arginine auxotroph despite the presence of all of the 
arg genes within its chromosome (39, 40).  While, transcription of argGH has 
been detected by northern blot analysis in a ccpA mutant, argJBCDF transcript 
has not been detected in any conditions tested.  Furthermore, S. aureus grown in 
the presence of 13C-glutamate yields no accumulation of 13C-arginine (41).   
These data suggest three major differences in S. aureus glutamate catabolism 
compared to B. subtilis.  First, S. aureus only encodes gudB for catabolism of 
glutamate into the TCA cycle intermediate, 2-oxoglutarate.  Additionally, the S. 
aureus genome does not encode orthologues to the B. subtilis proB/proJ, proA, 
or proI/proH/proG genes involved in proline synthesis via glutamate degradation.  
Lastly, S. aureus does not appear to utilize glutamate as a substrate for arginine 
biosynthesis via the argJBCDFGH pathway.    
Glutamine.   
Glutamine is an optimal source of nitrogen for many bacteria.  In the 
absence of glutamine, ammonium can be used as a source of nitrogen through 
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assimilation with glutamate via glutamine synthetase (GS) and GOGAT.  In this 
cycle, GS (glnA) is expressed in the absence of glutamine and functions to 
convert glutamate and ammonium into glutamine (42).  GOGAT, encoded by 
gltAB, produces two glutamate molecules from glutamine and 2-oxoglutarate via 
reductive amination.  In this reaction, glutamine provides an amide group to 2-
oxoglutarate, resulting in the synthesis of glutamate.  GOGAT is only synthesized 
in the presence of its substrates, 2-oxoglutarate and glutamine (12, 25, 27).  S. 
aureus encodes both GS and GOGAT genes, however, few studies have been 
performed to elucidate how glutamate/glutamine metabolism functions in S. 
aureus.   
Proline.   
In B. subtilis, proline can be utilized as a sole source of carbon or nitrogen 
through its oxidation into glutamate via the putBCP operon (43).  Proline 
dehydrogenase (PutB) catalyzes the conversion of proline into Δ1-pyrroline-5-
carboxylate (P5C), which is then spontaneously hydrolyzed to γ-glutamate-5-
semialdehyde.  The NAD-dependent Δ1-pyrroline-5-carboxylate dehydrogenase 
(PutC) then oxidizes γ-glutamate-5-semialdehyde further into glutamate.  The 
high affinity proline transporter, PutP, is well suited for scavenging proline from 
scarce nutritional environments (43-45).  The expression of the putBCP operon is 
dependent on the proline-responsive activator protein, PutR.  PutR requires only 
submillimolar concentrations of proline for induction of putBCP (43, 46).  CodY, a 
global transcriptional regulator of metabolic genes, represses putBCP 
transcription by displacing PutR (46).  The presence of proline dehydrogenase 
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(putA), Δ1-pyrroline-5-carboxylate dehydrogenase (rocA), and putP in the S. 
aureus genome indicates the ability to transport and catabolize proline.  
However, unlike B. subtilis, these genes are not found in an operon and there 
does not appear to be an orthologus putR gene present within the genome.   
In S. aureus, proline can also serve as a substrate for arginine 
biosynthesis when grown on non-preferred carbon sources.  It has been known 
since the 1930’s that most strains of S. aureus exhibit multiple amino acid 
auxotrophies when grown in media containing glucose, including arginine and 
proline (39, 47).  However, genomic analyses have shown that the S. aureus 
genome contains genes necessary for the synthesis of all 20 amino acids (40).  It 
has been recently understood that some of these pathways, such as the 
interconversion of proline and arginine, are repressed by CcpA and are only 
induced when growing on non-preferred carbon sources (5, 37, 41).  Nuxoll and 
colleagues demonstrated that alleviation of CcpA repression mediates arginine 
biosynthesis via proline degradation by proline dehydrogenase and the urea 
cycle.  Moreover, S. aureus grown in the presence of 13C-proline yields 
accumulation of 13C-arginine (41).      
Arginine.   
Arginine catabolism has been extensively studied as many bacteria 
contain more than one arginine catabolic pathway (38).  B. subtilis can utilize 
arginine as a sole nitrogen and carbon source through its conversion to 
glutamate via the arginase pathway, generating two molecules of glutamate per 
one molecule of arginine.  The arginase pathway is encoded by two operons, 
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rocABC and rocDEF, and converts arginine into glutamate in three enzymatic 
steps.  First, arginine is cleaved by arginase, encoded by rocF, into ornithine.  
Ornithine is converted to γ-glutamate-5-semialdehyde via ornithine 
aminotransferase (RocD).  In the last step of the arginase pathway, the 
conversion of γ-glutamate-5-semialdehyde into glutamate is catalyzed by RocA.  
While the protein encoded by rocB is of unknown function, rocC and rocE are 
hypothesized to encode amino acid permeases (32, 38, 48).  Induction of these 
operons requires the positive transcriptional regulator RocR and the presence of 
arginine, ornithine, citrulline, or proline.  A second regulatory protein, AhrC, also 
controls the expression of the arginase pathway.  In the presence of arginine, 
AhrC acts as a positive regulator of rocF and rocD transcription, while repressing 
the arginine biosynthetic arg operon (48).  S. aureus encodes all the genes 
necessary to convert arginine to glutamate via the arginase pathway.  As 
previously mentioned, the S. aureus genome does not appear to encode an 
orthologus rocR gene.  However, it does encode an ahrC gene, though to date its 
function in the regulation of arginine catabolism has not been demonstrated.   
As previously discussed, S. aureus is an auxotroph for arginine and 
proline.  However, the interconversion of arginine and proline can be mediated 
with the alleviation of CcpA repression.  It has been demonstrated by Li et al. that 
S. aureus can utilize arginine as a substrate for proline synthesis in the absence 
of glucose via the Δ1-pyrroline-5-carboxylate reductase pathway, which utilizes 
RocF and RocD, along with Δ1-pyrroline-5-carboxylate reductase (ProC).  
Furthermore, it was demonstrated that when grown in the presence of 
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radiolabeled arginine, S. aureus accumulates radiolabeled proline, indicating 
arginine is serving as a precursor to proline biosynthesis (5, 37). 
Arginine can also be catabolized via the highly conserved arginine 
deiminase (ADI) pathway.  ADI catalyzes the conversion of arginine into 
ornithine, ammonia, and carbon dioxide, as well as the production of 1 mol of 
ATP per 1 mol of arginine consumed.  ADI is comprised of three enzymes: 
arginine deiminase (ArcA), ornithine carbamoyl transferase (ArcB) and 
carbamate kinase (ArcC), which are encoded by the arc operon.  The arc operon 
also encodes an arginine/ornithine antiporter (ArcD) and two regulatory proteins, 
ArgR and ArcR, which are dependent on arginine availability and anaerobic 
conditions respectively (38, 49).  Recently, increased attention has been drawn 
to the ADI pathway in endemic S. aureus USA300 strains due to the acquisition 
of a second copy of the arc operon found on the arginine catabolic mobile 
element (ACME), which is hypothesized to contribute to the success of this 
particular methicillin-resistant community associated S. aureus (CA-MRSA) strain 
in colonizing acidic environments such as the skin (50, 51).   
Transcription of the arc operon is subject to CcpA repression and is often 
arginine dependent via the ArgR family of transcriptional regulators, ArgR and 
AhrC (52-55).  Expression of the arc operon is also induced under anaerobic 
growth conditions and dependent upon ArcR, which is also encoded within the 
arc operon (49).  In lactic acid bacteria it has been demonstrated that ADI 
functions to mediate pH homeostasis and survival under low-pH stress via 
ammonia synthesis (55, 56).  In S. aureus USA300, it has been demonstrated 
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that the acquisition of ACME has increased the pathogen’s ability to colonize the 
skin, partially due to the contributions of ADI to pH homeostasis (51).  
Furthermore, ammonia from ADI in Staphylococcus epidermidis contributes to 
biofilm development, as well as pH homeostasis in the presence of organic acids 
(57).  The ATP generated via ADI also has the ability to provide S. aureus with 
energy in nutrient limiting conditions, thus making ADI a critical component for 
successful host colonization.   
Arginine serves as a substrate for NO synthesis, a highly reactive free 
radical gas, which is produced via the NO synthase enzymes (NOS).  NOS is 
well characterized in mammals and involved in a wide variety of cellular 
processes, including protection against pathogens (58).  A number of bacterial 
NOS enzymes have also been identified in gram-positive species, including S. 
aureus, with diverse functions in virulence, biofilm development, toxin synthesis, 
and antibiotic resistance (59-61).  Currently in S. aureus, there is evidence that 
NOS contributes to hydrogen peroxide resistance and may be involved in 
staphyloxanthin production (62).  Overall, arginine is involved in several 
metabolic pathways important for survival within the host, including pH 
homeostasis, energy production, and carbon and nitrogen metabolism, all 
contributing to the virulence and success of the pathogen.   
Histidine.  
The histidine utilization (Hut) system is a widely distributed pathway 
amongst bacteria in which histidine is degraded into glutamate.  The first three 
steps in this pathway appear to be universal, in which histidase (HutH) removes 
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ammonia from histidine, yielding urocanate.  The hydration of urocanate to 
imidazolone propionate (IP) is catalyzed by urocanase (HutU), followed by the 
ring cleavage of IP by IP hydrolase (HutI) to yield formiminoglutamate (FIG).  
Two pathways can utilize FIG; one generates glutamate in a two-step reaction 
via FIG deiminase and formyl glutamate hydrolase (FGase) (63, 64).  Another 
pathway, found in B. subtilis, involves the hydrolysis of FIG to glutamate by FIG 
hydrolase (HutG) (65).   
Histidine synthesis requires an input of 20 high-energy phosphate bonds, 
thus being one of the most expensive amino acids for the cell to synthesize (66).  
Therefore, it is of no surprise that its degradation is stringently regulated.  The 
regulation of the hut pathway has been studied extensively in several bacteria 
including Klebsiella pneumoniae, several Pseudomonas species, and B. subtilis.  
The details of the regulatory mechanisms controlling histidine utilization differ 
considerably among these bacteria; however, most species share several 
common features including the following: (i) Exogenous hisitidine must be 
present at higher concentrations than internal pools generated by histidine 
synthesis for expression of hut genes.  (ii) Only if cells are limited in some 
essential requirement that degradation of histidine can fulfill, such as a carbon 
source, will the Hut enzymes be maximally expressed.  (iii) The affinities of the 
histidine degradative enzymes and the tRNA synthetases for histidine are such 
that internal pools of histidine are not depleted below levels that would halt 
protein synthesis (67).   
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In B. subtilis, three proteins (HutP, CcpA, and CodY), acting at three 
different sites within the operon, regulate hut transcription.  The hutP gene, 
located just upstream of hutHUIG, encodes an antiterminator protein that binds to 
a termination stem-loop structure located between hutP and the enzyme-
encoding genes of the operon in the presence of histidine, allowing for read 
through of the termination signal (68, 69).   The hut operon is also strongly 
repressed by availability of carbon sources via CcpA.  In the presence of 
glucose, CcpA binds to catabolite responsive elements (cre) located within the 
hut promoter and the hutP coding sequence, exerting repression of the hut 
operon (70-72).  Transcription of hut genes are also strongly repressed when 
grown in the presence of amino acids by CodY binding to an operator site 
(hutOA) just downstream from the hut promotor (69).  To date, there is little 
knowledge of histidine utilization in S. aureus or the regulation thereof.   
Oxaloacetate generating amino acids: 
Oxaloacetate is a TCA cycle intermediate that provides a link between 
gluconeogenesis/glycolysis, the TCA cycle, and amino acid metabolism.  
Oxaloacetate can be utilized in several reactions that direct the carbon flux within 
central metabolism to ensure efficient use of available carbon sources.  The 
synthesis of citrate, which is catalyzed by citrate synthesis (GltA) via the 
substrates oxaloacetate and acetyl-CoA, is essential for full TCA cycle activity 
and generation of energy via respiration.  However, in the absence of glycolytic 
sugars oxaloacetate can fuel gluconeogenesis through phosphoenolpyruvate 
carboxykinase (PckA) activity, which catalyzes the GTP-dependent formation of 
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phosphenolpyruvate (PEP) from oxaloacetate (73-75).  In B. subtilis, mutants 
lacking PckA cannot grow on non-glycolytic carbon sources, as they are unable 
to synthesize glycolytic intermediates necessary for growth and replication, such 
as precursors for peptidoglycan synthesis (75).    
Oxaloacetate occupies a key position in central metabolism in which it can 
be utilized as a substrate in several different pathways depending on nutrient 
availability.  Therefore, it is of no surprise that multiple pathways also exist to fuel 
its synthesis.  Oxaloacetate, the beginning metabolite of gluconeogenesis, can 
be synthesized from pyruvate via pyruvate carboxylase (Pyc), a reaction utilized 
to replenish TCA cycle intermediates.  Pyc is constitutively expressed and 
subject to strong allosteric activation by acetyl-CoA (75).  Asparagine and 
aspartate are also able to fuel oxaloacetate synthesis via the hydrolysis of 
asparagine to aspartate by the enzyme, asparaginase (AnsA).  Aspartate can 
then be converted to oxaloacetate by aspartate aminotransferase (AspB), which 
catalyzes a transamination reaction via the conversion of aspartate and 2-
oxoglutarate to oxaloacetate and glutamate.   It is of importance to note that the 
aspartate provides the carbon backbone for oxaloacetate in this reaction. This 
reaction is also reversible, allowing for oxaloacetate to fuel aspartate and 
asparagine synthesis if needed (76).  When carbon availability is scarce, B. 
subtilis is able to fuel oxaloacetate synthesis and subsequent gluconeogenic 
reactions via utilization of aspartate/asparagine, a process that is hypothesized to 
be involved in sporulation (74, 75).  S. aureus also has the ability to convert both 
asparagine and aspartate to oxaloacetate via the asparaginase (AnsA) and 
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aspartate aminotransferase (AspA) enzymes, however, the contribution of these 
amino acids to central metabolism remains unknown.   
Pyruvate generating amino acids:  
Pyruvate is a versatile metabolic intermediate, generated from the 
breakdown of glucose through glycolysis.  Pyruvate can be utilized to generate 
acetyl-CoA, which either enters the TCA cycle or is converted to acetate, both 
pathways generating ATP (77).  It can also be converted to acetoin during carbon 
overflow metabolism to avoid over-production of potentially harmful weak-acids 
(78).  During anaerobic fermentation, pyruvate is converted to lactate for the 
regeneration of NAD+ and redox balance.  As previously discussed, pyruvate can 
also be used as an acceptor of carbon dioxide to replenish oxaloacetate levels 
and the TCA cycle via Pyc (75, 77).  The synthesis of several metabolites, 
including amino acids, also require pyruvate as a precursor (76).   
When carbon availability is limited, several amino acids can fuel pyruvate 
synthesis.  Both B. subtilis and S. aureus have the ability to directly convert 
serine and alanine to pyruvate via serine dehydratase (SdaAB) and alanine 
dehydrogenase (Ald), respectively.     Furthermore, threonine and glycine can be 
converted to serine and subsequently pyruvate via SdaAB, while cysteine can be 
converted to alanine and then pyruvate via Ald.  While little is known about the 
function of serine utilization in B. subtilis metabolism, it has been demonstrated 
alanine can be utilized as a sole carbon or nitrogen source through its conversion 
to pyruvate and ammonia via Ald.  It has also been demonstrated that Ald is 
necessary for normal sporulation in B. subtilis (79, 80).  It is unclear, however, 
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how these amino acids contribute to central metabolism in S. aureus when 
carbon sources are limited.   
The work described in this dissertation is designed to gain a better 
understanding of the pathways involved in amino acid catabolism in S. aureus, 
as utilization of these pathways may be critical during host colonization and 
infection.  Knowledge of these metabolic networks may help gain insight into 
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Bacterial strains and culture conditions.   
The S. aureus strains used in this study are all derived from JE2, which is the 
parent strain of the Nebraska Transposon Mutant Library (NTML) (81).  Defined 
bursa aurealis transposon mutants were obtained from the NTML (81).  JE2 ccpA 
and JE2 ackA have been previously described (41, 82, 83).  S. aureus strains 
were grown in either tryptic soy broth (TSB; Becton Dickinson, Franklin Lakes, 
NJ), complete defined medium (CDM) as previously described (84) except no 
glucose was added, or CDM with 0.25% glucose (CDMG).  Cultures were grown 
aerobically in a 1:10 volume to flask ratio, shaking at 250 rpm at 37°C.  S. aureus 
cultures were inoculated to 0.05 optical density at 600 nm (OD600) from overnight 
cultures grown in either TSB, CDM or CDMG.  Bacterial growth was assessed by 
measuring the optical density at 600 nm.  Anaerobic growth was measured in an 
anaerobic chamber (Coy Laboratory Products, Inc., Grass Lakes, MI) using a 
10:1 flask-to-volume ratio in CDM supplemented with 1.0 g/liter L-cysteine 
hydrochloride (Sigma) with or without the addition of L-lactate (0.5%) and/or 
sodium nitrate (20 mM).  Growth was assessed in the anaerobic chamber with 
shaking at 37°C at 250 rpm to ensure that the cells did not settle in the flask.  For 
time-kill curves, 100 µM of N,N′-dicyclohexylcarbodiimide (DCCD) in 95% ethanol 
was added to cultures during early exponential growth (OD600=0.5 for CDM and 
1.0 for TSB and CDMG).   
Construction of JE2 ΔahrC mutant 
	 26	
All primers (TABLE) used for construction and confirmation of the ahrC deletion 
were generated based on the sequence of S. aureus USA300_FPR3757 
(NC_007793.1).  pNF293, the JE2 ΔahrC allelic replacement construct, was first 
created by insertion of an 861-bp ahrC upstream PCR product (using primers 
1999 and 2000; TABLE) into the EcoR1 and BAMH1 sites of pUC19 (85). 
Second, a 755-bp ahrC downstream PCR product was amplified (using primers 
2211 and 2212; TABLE) and ligated into the BamH1 and Pst1 sites of the pUC19 
polylinker.  The temperature-sensitive pE194 derivative pROJ6448 was ligated 
into the PstI site of the plasmid (86).  The completed construct, pNF293, was 
electroporated into the RN4220 restriction-negative S. aureus strain (87).  
Modified plasmid DNA was isolated using Wizard Plus MidiPrep kits (Promega, 
Madison, WI) and transduced into S. aureus JE2 using phage 80α as previously 
described (88).  Allelic replacement was performed using previously described 
methods (89).  Genetic sequencing (Eurofins Genomics) using primers 2944 and 
2945 confirmed in-frame deletion of ahrC in JE2 ΔahrC. 
Construction of JE2 arcA1::kan arcA2::ΝΣ and JE2 rocF::tetL arcA1::kan 
arcA2::ΝΣ mutants 
 The pKan plasmid (89) was transduced (88) into transposon mutant  JE2 
arcA1::ΝΣ and allelic replacement was performed using previously described 
methods (89) to construct JE2 arcA1::kan and confirmed by PCR and southern 
blot analyses.   JE2 arcA1::kan was transduced (88)  into JE2 arcA2::ΝΣ to 
construct JE2 arcA1::kan arcA2::ΝΣ.  To construct JE2 rocF::tetL arcA1::kan 
arcA2::ΝΣ mutants, pTet plasmid (89) was transduced (88) into the transposon 
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mutant  JE2 rocF::ΝΣ and allelic replacement was performed using previously 
described methods (89) to construct JE2 rocF::tet.  JE2 rocF::tet was transduced 
(88) into JE2 arcA1::kan arcA2::ΝΣ to construct JE2 rocF::tet arcA1::kan 
arcA2::ΝΣ. 
Measurement of bacterial metabolites.  Bacterial cultures were collected (1 ml 
aliquots) and centrifuged at 14,000 rpm for 3 min.  The supernatants were 
removed and stored at -80°C until use.  Acetic acid, glucose, ammonia, and D- 
and L-lactic acid concentrations were determined using kits purchased from R-
Biopharm, according to manufacturer instructions.	
Measurement of TCA cycle and respiration activity. For all assays, JE2 was 
grown overnight aerobically in 25 ml of appropriate media. Cultures were 
inoculated to an OD600 of 0.05 in TSB, CDM, or CDMG and were grown to early 
exponential phase (OD600=0.5 for CDM and 1.0 for TSB and CDMG).  These 
data were analyzed using an unpaired t-test.  A P value of ≤0.05 was considered 
statistically significant.   
ATP concentration:  Intracellular ATP concentrations were determined using the 
BacTiter-Glo kit (Promega) according to the manufacturer’s protocol and 
normalized to total optical units.  
NAD+/NADH concentration:  Aliquots of bacterial cultures (24 ml) were harvested 
by centrifugation at 4°C for 10 min at 4,000 rpm. Intracellular NAD+ and NADH 
concentrations were determined using Fluoro NAD+/NADH kit (Cell Technology) 
as previously described (82) and normalized to total cellular protein 
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concentrations.  
Oxygen consumption: Samples were collected and diluted in air-saturated TSB, 
CDM, or CDMG to an OD600 of 0.3. Relative oxygen consumption rates were 
determined for up to 120 min at 37°C by using a MitoXpress oxygen-sensitive 
probe (Luxcel Biosciences) according to the manufacturer’s instructions and 
normalized to total optical units.  
Citrate concentrations:  Aliquots of bacterial cultures (24 ml) were harvested by 
centrifugation at 4°C for 10 min at 4,000 rpm. The bacterial pellets were washed 
twice with 1 ml of phosphate-buffered saline, pH 7.4 (PBS) and subsequently 
resuspended in 1 ml PBS. The cells were lysed using lysing matrix B tubes in a 
FastPrep FP120 instrument (Qbiogene). The lysates were centrifuged for 3 min 
at 14,000 rpm and deproteinized using perchloric acid/KOH. Citrate 
concentrations in the lysates were determined by using a Citrate fluorometric 
assay kit (BioVision) according to the manufactures protocol and normalized to 
total cellular protein concentrations.  
Amino acid analysis. JE2 was grown overnight in 50 ml (500 ml flask) of TSB or 
CDMG.  Cultures were inoculated to an OD600 of 0.05 in TSB (from TSB 
overnight), CDM, CDMG, and CDMP (all from CDMG overnight) and grown for 
12 hours.  1 ml of media was collected every 4 hours and centrifuged for 3 min at 
14,000 rpm.  Supernatant was collected and filterd through 3,000 MWCO Amicon 
Ultra centrifugal filters (Millipore) according to the manufacturer’s protocol.  
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Amino acid analysis was performed by the Protein Structure Core Facility, 
UNMC, using a Hitachi L-8800.  
NMR sample preparation.  Three independent 50-ml cultures of S. aureus JE2 
were grown to exponential phase (4hr-6hr) and stationary phase (8hr-10hr) in 
CDM, CDMG, and CDMP containing either 13C5-glutamate, 13C5-proline, 13C5-
arginine, 13C5-glucose, or 13C5-pyrutate (Sigma-Aldrich).  Cultures were 
normalized to an OD600 of 40 and pelleted by centrifugation (6000 rpm at 4°C for 
5 min).  Pelleted cells were subsequently washed two times with 10 ml of cold 
sterile water and resuspended in 1 ml cold sterile water and transferred to a 
lysing matrix B tube (MP Biomedicals).  The cells were lysed using an FP120 
FastPrep cell disrupter (MP Biomedicals) and centrifuged at 13,200 rpm for 15 
min at 4°C. The pelleted debris was resuspended in 1 ml of cold sterile water 
centrifuged again as above. Supernatants from the two centrifugation steps were 
combined and stored at -80°C for NMR analysis.  
NMR data collection and analysis. The collected supernatants were lyophilized 
and reconstructed in NMR buffer (KH2PO4/K2HPO4 buffer in D2O, pH 7.4, with 
500 uM TMSP as an internal standard). 2D 1H-13C HSQC spectra were 
collected on a Bruker DRX Avance 500-MHz spectrometer equipped with a 5-mm 
triple-resonance cryoprobe (1H, 13C, and 15N) with a z-axis gradient, a BACS-
120 sample changer, Bruker ICON-NMR, and an automatic tuning and matching 
(ATM) unit. NMRPipe (28) and NMRViewJ (29) were used to process and 
analyze collected spectra. After being referenced in chemical shift and 
normalized in intensity to the internal standard TMSP, peaks were annotated by 
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comparing their chemical shifts to the metabolite reference data from	 the 
Platform for RIKEN Metabolomics (PRIMe, http://prime.psc.riken.jp/) (30), Human 
Metabolome Database (HMDB, http://www.hmdb.ca/) (31), Madison 
Metabolomics Consortium Database (http://mmcd.nmrfam.wisc.edu/) (32), 
Metabominer (http://wishart.biology.ualberta.ca/metabominer/) (33), and 
BiomagResBank (BMRB, http://www.bmrb.wisc.edu/) (34) with an error tolerance 
of 0.08 ppm and 0.25 ppm for 1H and 13C chemical shifts, respectively.	 The 
intensity of each metabolite was calculated by averaging the intensities of peaks, 
which were unambiguously assigned to the metabolite.   
RNA isolation and northern blot analysis.  Cultures of S. aureus JE2 and JE2 
ccpA were grown overnight in TSB, CDM and CDMG and inoculated to an OD600 
of 0.05 into TSB (TSB overnight), CDM, CDMG, respectively.  Cultures were 
grown at 37°C in a 1:10 volume to flask ratio at 250 rpm.  15 ml of bacterial 
culture were collected at mid-exponential phase (3hr-6hr) and post-exponential 
phase (7hr-10hr) of growth and centrifuged at 5,000 rpm for 10 min at 4°C.  Cell 
pellets were resuspended in RLT buffer with 1% β-mercaptoethanol and 
transferred to lysing matrix B tubes (MP Biomedicals).  They were then 
processed in an FP120 FastPrep cell disrupter (MP Biomedicals) for 24 s at a 
setting of 6.0.  Cells were then pelleted at 13,000 rpm for 15 min at 4°C.  The 
top-phase was combined with 500 µL of ethanol and the samples were then 
processed using an RNeasy mini kit, according to manufacturer’s instructions 
(Qiagen, Inc.)  Primers listed in Table S2 were used to make DNA probes that 
were subsequently labeled with digoxigenin-labeled dUTP (Roche).  1 µg of RNA 
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was used for northern analysis that was performed using DIG buffers and 
washes (Roche).  Anti-Digoxigenin-AP Fab fragments (Roche) was used with 
ECF substrate (GE Healthcare) for detection.  Blots were visualized using the 
























Table 2.1 Bacterial strains and plasmids used in this study 
Bacterial Strain or 
Plasmid Relevant Phenotype Source 
pUC19 Gram-negative origin of replication, Ampr Invitrogen 
pROJ6448 
pE194 containing pC221 nick site 
functioning in conjugative mobilization, 




ahrC allelic replacement vector for 
makerless, in-frame ahrC mutant; AmpR, 
ErmR 
This study 
E. coli DH5α 
 





S. aureus RN4220 Restriction deficient NCTC8325-4 (90) 
S. aureus JE2 LAC cured of all 3 native plasmids  (91) 
S. aureus JE2 
ald::ΝΣ 
bursa aurealis mutation in alanine 
dehydrogenase This study 
S. aureus JE2 
sdaAA::ΝΣ 
bursa aurealis mutation in serine 
dehydratase, alpha subunit This study 
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S. aureus JE2 
aspA::ΝΣ 
bursa aurealis mutation in aspartate 
amino transferase This study 
S. aureus JE2 
ansA::ΝΣ bursa aurealis mutation in asparaginase This study 
S. aureus JE2 
rocF::ΝΣ bursa aurealis mutation in arginase This study 
S. aureus JE2 
putA::ΝΣ 
bursa aurealis mutation in proline 
dehydrogenase This study 
S. aureus JE2 
gudB::ΝΣ 
bursa aurealis mutation in glutamate 
dehydrogenase This study 
S. aureus JE2 
hutU::ΝΣ 
bursa aurealis mutation in urocanate 
hydratase This study 
S. aureus JE2 
sucA::ΝΣ 
bursa aurealis mutation in 2-oxoglutarate 
dehydrogenase, EI component This study 
S. aureus JE2 
sucC::ΝΣ 
bursa aurealis mutation in succinyl-CoA 
synthetase, beta subunit This study 
S. aureus JE2 
sdhA::ΝΣ 
bursa aurealis mutation in succinate 
dehydrogenase, flavoprotein subunit This study 
S. aureus JE2 
fumC::ΝΣ 
bursa aurealis mutation in fumerate 
hydratase This study 
S. aureus JE2 
mqo1::ΝΣ 
bursa aurealis mutation in malate 
quinone oxidoreductase This study 
S. aureus JE2 
pckA::ΝΣ 
bursa aurealis mutation in phosphoenol 
pyruvate carboxykinase This study 
S. aureus JE2 
ΔackA::ermB  Allelic exchange mutant in ackA; Erm
r (82) 
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S. aureus JE2 
pyc::ΝΣ 
bursa aurealis mutation in pyruvate 
carboxylase This study 
S. aureus JE2 
arcA1::kan 
arcA2::ΝΣ 
bursa aurealis mutations in arcA1 and 
arcA2; TetR, ErmR, KanR This study 




bursa aurealis mutations in rocF, arcA1, 
and arcA2; ErmR, KanR This study 
S. aureus JE2 
gltA::ΝΣ 
bursa aurealis mutation in citrate 
synthase This study 
S. aureus JE2 
acnA::ΝΣ bursa aurealis mutation in aconitase This study 
S. aureus JE2 
icd::ΝΣ 
bursa aurealis mutation in isocitrate 
dehydrogenase This study 
S. aureus JE2 
gltB::ΝΣ 
bursa aurealis mutation in glutamate 
synthase, large subunit This study 
S. aureus JE2 
rocD::ΝΣ 
bursa aurealis mutation in ornithine 
amino transferase This study 
S. aureus JE2 
rocA::ΝΣ 
bursa aurealis mutation in Δ1-pyrroline-5-
carboxylate dehydrogenase This study 
S. aureus JE2 
argR1::ΝΣ 
bursa aurealis mutation in 
SAUSA300_2571, arginine repressor This study 
S. aureus JE2 
argR2::ΝΣ 
bursa aurealis mutation in 
SAUSA300_0066, arginine repressor This study 
S. aureus JE2 
codY::ΝΣ 
bursa aurealis mutation in 
SAUSA300_1148 This study 
	 35	
S. aureus JE2 
ΔahrC 
Markerless deletion in SAUS200_1469, 
arginine repressor This study 
pKAN pTnT with aphA-3 (89) 
pTET pTnT with tet(M) (89) 
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Table 2.2 Oligonucleotides used in this study 
Name Sequence (5’ to 3’) Target 
2838 GCTTCATCAACATGGCGTAA Forward primer to amplify putA 
2839 ATGATGCGATGGTCATGTGT Reverse primer to amplify putA 
2840 TTCCACCCAGATGTTGATGA Forward primer to amplify gudB 
2841 GGCATTACCGAAACCTTGAA Reverse primer to amplify gudB 
2932 GAAGCAGTTGGTGATGCAGC Forward primer to amplify rocA 
















Forward primer to 
amplify rocF 
2837 GAACGCCATCAACATTGCGT Reverse primer to amplify rocF 
3100 GGACAGATGACAGCCGGTAG  
Forward primer to 
amplify hutU 
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3101 AGCCTGGGAAGTCAAAAGCA  



















































 S. aureus has the ability to establish infections in a wide variety of metabolic 
niches within the human host including, among others, the heart, bone, kidney, blood, 
and soft tissue. Significant advances have been made in the study of bacterial virulence 
factors and their functions in human disease and infection of these various organ 
systems.   However, we have only begun to study how particular carbon and nitrogen 
sources that are available to S. aureus in specific host niches affect virulence factor 
expression and subsequent invasion, metastasis or quiescence. As these metabolic 
pathways are required for bacterial proliferation within the host, knowledge of these 
pathways may reveal novel avenues for drug development.  
A critical component of the innate immune response is the synthesis of nitric 
oxide (NO) by inducible nitric oxide synthase (iNOS) within activated phagocytes (92). 
Nitric oxide has wide ranging effects on bacterial cells including the disruption of lipid 
biosynthesis, central metabolism, respiration and DNA replication (93). Data from an 
evolving model demonstrates that, in contrast to other staphylococcal species, S. aureus 
has the ability to grow under NO stress by fermenting glucose via lactate dehydrogenase 
generating lactate and facilitating NAD+ regeneration to maintain glycolytic flux and 
redox balance (3, 10, 11, 94, 95). Under NO stress conditions, glycolysis is an essential 
process as a mutation in the glycolytic enzyme pyruvate kinase (pyk) severely inhibits 
initiation of abscess formation in a skin and soft tissue murine model (95). Indeed, 
inhibitors of pyruvate kinase have proved promising against S. aureus and other gram-
positive pathogens (96-99).  
Following invasion of host tissue, S. aureus replicates in abscess communities 
that are encapsulated within fibrin deposits and infiltrating immune cells (100). Much 
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recent work has led to an overarching view of abscess formation including the definition 
of essential virulence factors such as coagulase, Von Willebrand factor, ClfA, FnbpA, 
and FnbpB (101). As the abscess matures within the fibrin wall, the center includes a 
large cluster of viable cells called the staphylococcal abscess community (100, 102). It is 
hypothesized that these niches have low concentrations of NO allowing for respiratory 
activity (3, 103); however, it is predicted that S. aureus must grow on non-preferred 
carbon sources as glucose is not abundant (10, 104). Indeed, S. aureus lacks the ability 
to utilize phospholipids, triglycerides, and potentially other short chain fatty acids as 
carbon sources due to the lack of both β-oxidation and glyoxylate shunt pathways. 
Therefore, other carbon sources that are available include lactate, excreted from S. 
aureus during fermentative growth, as well as peptides and free amino acids. Recent 
work from Spahich and colleagues found that the addition of lactate plus peptides 
supports growth of S. aureus under low NO stress (10). Growth under these conditions 
was dependent upon lactate quinone oxidoreductase (lqo), which assimilates lactate in 
an NAD-independent manner and requires an electron acceptor such as oxygen or 
nitrate (11). Importantly, growth under these conditions also required peptides to serve 
as a carbon source to facilitate gluconeogenesis.            
 To date, little is known about amino acid catabolism in S. aureus; however, 
bioinformatics analysis suggests that pathways are present to catabolize multiple amino 
acids including those that generate pyruvate, 2-oxoglutarate, and oxaloacetate (Table 
1.1). Although it is unclear in which microniches amino acid/peptide catabolism is 
important, it has been presumed that S. aureus utilizes peptides/amino acids as carbon 
sources as it encodes multiple oligopeptide permeases and free amino acid transporters 
(6-8). In addition, S. aureus encodes metallo, serine and papain-like cysteine proteases 
that have the ability to degrade host proteins (9). We have recently demonstrated that at 
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least some of these amino acid catabolic pathways, such as those linking arginine and 
proline, are repressed by carbon catabolite repression (via CcpA) and are only induced 
when S. aureus is growing on non-preferred carbon sources (5, 37, 41). Thus, a S. 
aureus ccpA mutant interconverts arginine and proline via an intact urea cycle (5, 37, 
41).  
     In this study, we utilized genetic and NMR metabolomics approaches to investigate 
amino acid catabolism in S. aureus USA300 JE2. We found that glutamate catabolism 
via GudB, which functions to replenish the TCA cycle via 2-oxoglutarate, is required for 
growth in a glucose-free medium. In addition, ATP generated from the Pta/AckA 
pathway is also required for growth, presumably due to a significantly reduced 
respiration rate. These data provide a model suggesting that certain amino acid 
catabolic pathways are essential for growth in niches where glucose is limiting.  
Results 
Growth of S. aureus in Complete Defined Medium lacking glucose (CDM). 
Staphylococcal growth and central metabolism have been well studied in tryptic 
soy broth (TSB), which contains 14 mM glucose and an ill-defined concentration of 
peptides and free amino acids (1). Therefore, to fully assess amino acid catabolism, a 
complete defined medium was prepared as described by Hussain and colleagues except 
that no glucose was added (84). This medium contains 18 amino acids but excludes 
glutamine and asparagine. Aerobic growth of JE2 in CDM reached an OD600 maximum 
of 3.0 following 8 hours (Figure 3.1). 2.3 mM acetate was produced by 6 hours of growth 
(Figure 3.1) indicating catabolism of the glucogenic amino acids yielding pyruvate and 
the generation of acetate via Pta/AckA (82, 105). Acetate was subsequently consumed 
from the medium as a secondary carbon source and presumably oxidized via the TCA  
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Figure 3.1.  Growth of S. aureus JE2 in CDM.  Aerobic growth of 
JE2 in CDM displaying acetate and ammonia production. Data are 
representative of experiments performed three times.	
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cycle (Figure 3.1) (106). Amino acid analysis of the spent medium demonstrated that 
alanine, serine, glycine, threonine, arginine, proline, glutamate, and aspartate were 
rapidly consumed by 8 hours of growth, whereas histidine was not consumed until 12 
hours of growth (Figure 3.2). Consistent with these data was the generation of ammonia, 
which reached a maximum concentration of 4.3 mM at 6 hours of growth (Figure 3.1) 
and is indicative of amino acid catabolism (57). There was a gradual consumption of 
other amino acids (cysteine, lysine, phenylalanine, tyrosine, leucine, isoleucine, valine, 
and methionine) indicating probable use for protein synthesis but not for catabolic 
purposes (Figure 3.2).  Based on bioinformatics analyses, S. aureus JE2 encodes genes 
for enzymes that function to catabolize amino acids to the metabolic intermediates 
pyruvate (from alanine, serine, glycine, threonine, and cysteine), 2-oxoglutarate (from 
glutamate, glutamine, histidine, arginine, and proline), and oxaloacetate (from aspartate 
and asparagine) (Table 1.1). Complete catabolic pathways could not be identified for 
tryptophan, isoleucine, leucine, lysine, methionine, phenylalanine, tyrosine, and valine. 
Outside of cysteine, which was not catabolized by JE2 in CDM, these analyses agreed 
with our experimental observations as detailed in Figure 3.2. To determine which 
catabolic pathways are required for growth in CDM, mutants from each predicted 
pathway (Table 1.1: ald, alanine; sdaAA, serine, glycine, and threonine; aspA, aspartate; 
ansA, asparagine; rocF, arginine; putA, proline; gudB, glutamate; and hutU, histidine) 
were chosen from a sequence defined transposon library (81) and growth analysis was 
performed (Figure 3.3 and Figure 3.4A-H). These data demonstrated that of these genes 
mutated, only gudB (Figure 3.4G), which encodes glutamate dehydrogenase and 
catalyzes the reaction between glutamate and 2-oxoglutarate, was required for growth in 
CDM. In addition, a mutation within, hutU yielded a markedly increased lag phase 
(Figure 3.4H) whereas a mutation in putA (Figure 3.4F) resulted in a growth yield defect. 
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Figure 3.2.  Amino acid consumption of JE2 following growth 
in CDM.  JE2 was grown aerobically in CDM and amino acid 
concentrations (mM) were measured in the supernatant at 0, 4, 8 




Figure 3.3.  Amino acid catabolic pathways in S. aureus.  Green arrows 
indicate those mutations that result in no significant growth defect as compared 
to wild type JE2 in CDM.  Blue arrows indicate those mutations that result in 
intermediate growth defects as compared to wild type JE2 in CDM.  Red arrows 
indicate mutations that completely inhibit growth of JE2 in CDM.  Black arrows indicate 
that these pathways were not tested.  Please see Figure 3.4 for growth analyses.   
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Figure 3.4.  Growth of JE2 and transposon mutants in CDM.  Aerobic growth (250 
rpm, 1:10 volume to flask ratio, 37° C) of JE2 bursa aurealis mutants from the 
Nebraska Transposon Mutant Library in CDM.  Data represents means ± SEM of 
three biological replicates.  
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Figure 3.4. Growth of JE2 and transposon mutants in CDM.  Aerobic growth (250 
rpm, 1:10 volume to flask ratio, 37° C) of JE2 bursa aurealis mutants from the 
Nebraska Transposon Mutant Library in CDM.  Data represents means ± SEM of 
three biological replicates.  
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Figure 3.4.  Growth of JE2 and transposon mutants in CDM.  Aerobic growth (250 
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Collectively, these data suggest that carbon derived from glutamate and those amino 
acids that can be converted to glutamate, particularly proline and histidine, serve as the 
major carbon sources for fueling the TCA cycle and subsequent gluconeogenic reactions 
via phosphoenolpyruvate carboxykinase (pckA) (Figure 3.3). Based on these 
observations, we predicted that mutations in the TCA cycle enzymes generating 
oxaloacetate from 2-oxoglutarate would also be required for growth. Therefore, 
transposon mutants in sucA (2 oxoglutarate dehydrogenase), sucC (succinyl Co-A 
synthetase), sdhA (succinate dehydrogenase), fumC (fumarase), and mqo1 (malate 
dehydrogenase) were grown in CDM (Figure 3.4I-M). As predicted, no growth was 
observed with the sucA, sdhA, and fumC mutants (Figure 3.3, Figure 3.4I-L). However, 
growth, albeit delayed, was observed with the mqo1 mutant (Figure 3.3, Figure 3.4M). 
This suggests that oxaloacetate can also be supplied by aspartate/glutamate 
transamination via AspA. Indeed, an mqo1 mutant was unable to grow in CDM lacking 
aspartate (CDM-D; Figure 3.5). Lastly, as predicted, no growth was observed for the 
pckA mutant, which is a critical enzyme required for gluconeogenesis via the generation 
of phosphoenolpyruvate from oxaloacetate (Figure 3.3, Figure 3.4N).  The putA (proline), 
rocF (arginine), hutU (histidine), and rocA (arginine and proline) transposon mutants 
were grown in CDM lacking glutamate (CDM-E) to determine which amino acid 
substrates that fuel glutamate synthesis are most crucial (Figure 3.6). As a result we 
found that the putA and rocA mutants had significant growth yield defects whereas 
mutations in rocF and hutU had only moderate growth defects compared to wildtype JE2 
grown in CDM-E. Thus, these data show that proline, arginine and histidine all serve to 
fuel glutamate synthesis when glutamate is limiting; however, proline via PutA and RocA 
is the major source of glutamate.  
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Figure 3.5.  Growth of S. aureus JE2 in CDM-D.  Growth of JE2 and JE2 
mqo1::NΣ in CDM lacking aspartate (CDM-D).  Data represents means ± 




                              
Figure 3.6.  Growth of S. aureus JE2 in CDM-E. Growth of JE2 
putA::NΣ, JE2 rocF::NΣ, JE2 rocA::NΣ, and JE2 hutU::NΣ in CDM lacking 
glutamate (CDM-E) in comparison to wildtype JE2.  Data represents 
means ± SEM of three biological replicates.  
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 As shown in Figure 3.1, growth of JE2 in CDM produces acetate suggesting that 
the glucogenic amino acids generating pyruvate (serine, threonine, glycine, and alanine) 
are important for ATP synthesis via substrate-level phosphorylation in the Pta/AckA 
pathway (82). To determine the importance of this pathway, JE2 ΔackA (82) was grown 
in CDM and, as shown in Figure 3.4O and Figure 3.3, growth was significantly reduced 
suggesting that generation of ATP via this pathway may be critical to growth using amino 
acids as carbon sources. Lastly, we found only a minor growth defect with the pyc 
mutant, suggesting that pyruvate flux is directed primarily towards acetate synthesis, 
instead of oxaloacetate and the TCA cycle (Figure 3.4P and Figure 3.3).                
NMR metabolomic analysis of amino acid catabolism in S. aureus. 
The previously described experiments suggested that proline primarily serves to 
fuel glutamate synthesis and thus may serve as the major carbon source to fuel 
gluconeogenesis when glutamate is limiting. In addition, it is predicted that the 
glucogenic amino acids serine, threonine, glycine and alanine are primarily catabolized 
to acetate to fuel ATP synthesis. To address these hypotheses and to determine the fate 
of carbon following amino acid catabolism, 13C labeled glutamate, arginine, proline, 
aspartate, histidine, serine, threonine, alanine, and glycine were individually added to 
CDM and assayed via NMR metabolomics in mid- and post-exponential growth.  
Glutamate, proline, and arginine 
Metabolic intermediates originating from 13C labeled glutamate, proline and 
arginine were very similar and included gluconeogenic intermediates (glucose-6-P and 
phosphoglycerate), and intermediates that function in nucleotide biosynthesis 
(dihydroorotate, ribose, uracil and adenosyl homocysteine) and glycolipid/lipoteichioic 
acid synthesis (glucose 1-phosphate) (Figure 3.7 and Figure 3.8A-C) (107). In addition, 
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both aspartate and asparagine were detected from all three 13C labeled amino acids 
suggesting these amino acids were synthesized from oxaloacetate and the TCA cycle. It 
is important to note that glutamate was synthesized from both proline and arginine, 
presumably via RocA (Figure 3.3, Figure 3.7, and Figure 3.8A-C). However, as 
previously reported, proline and arginine were not produced from glutamate (41). 
Importantly, these results suggest proline and arginine can both serve as carbon 
sources as they both serve as precursors for glutamate, the key intermediate linking 
carbon and nitrogen metabolism. However, the relative amount of glutamate generated 
from proline was approximately five-fold greater than the amount generated from 
arginine (Figure 3.7, Figure 3.8B and 3.8C). And, as previously noted, a mutation in rocF 
had minimal effect on growth in CDM and CDM-E. It is important to note that JE2 
contains two copies of arginine deiminase, which can generate citrulline and ornithine 
from arginine while bypassing RocF (50, 57). However, an arcA1/arcA2 arginine 
deiminase mutant also had no significant growth defect in CDM (Figure 3.4Q). Thus, 
these NMR data are consistent with our genotypic growth analysis and show that proline 
is rapidly catabolized to generate glutamate and facilitate subsequent gluconeogenic 
reactions.        
Previous work demonstrated that arginine is synthesized via proline and the urea 
cycle in a ccpA mutant (41) but not through the well-defined glutamate to arginine 
pathway as described in B. subtilis and other bacteria (38). Although genes for the arg 
pathway are present in S. aureus, growth conditions where they are induced are not 
known. In a similar manner, work from others (5, 37) demonstrated that arginine served 
as a precursor for proline biosynthesis in a ccpA mutant via RocF, RocD, and ProC. 
Electrophoretic mobility shift assay (EMSA) analysis demonstrated that CcpA bound to 
the promoters of both rocF and rocD, but not proC (5). 
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Figure 3.7.  Summary of cellular metabolite concentration changes resulting 
from uniformly labeled amino acids supplemented in CDM.  Summary on 
following page. 
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Figure 3.7.  Summary of cellular metabolite concentration changes resulting from 
uniformly labeled amino acids supplemented in CDM. The bubble plot summarizes 
the metabolites derived from [U-13C4] aspartate (D), [U-13C5] glutamate (E), [U-13C5] 
proline (P), [U-13C6] histidine (H), [U-13C6] arginine (R), [U-13C4] threonine (T), [U-13C3] 
serine (S), [U-13C3] alanine (A) or [U-13C2] glycine (G) based on an analysis of triplicate 
2D 1H-13C HSQC experiments. Due to the wide dynamic range of NMR intensities, the 
original NMR peak intensities were transformed by natural logarithm for the purpose of 
visualization. The relative size of the bubble indicates the transformed value where a 
larger diameter indicates a higher NMR peak intensity. The bubbles are colored using a 
red color-gradient to represent the original NMR peak intensity, where an increase in red 
color intensity represents a corresponding increase in the original NMR peak intensity. 
Each level increase in red intensity corresponds to a tenfold increase in the NMR 
intensity. The bubbles with a purple outline ( ) identify metabolites observed during 
exponential phase. Bubbles with a green outline ( ) identify metabolites observed 
during stationary phase. Metabolite names are colored based on an assigned category: 
urea cycle (orange), amino acid (green), glycolysis/gluconeogenesis (black), pentose 




Figure 3.8  NMR Peak intensity of CDM supplemented with 13C labeled amino 
acids.  Metabolites derived from [U-13C5] glutamate (E) (A),  [U-13C5] proline (P) (B), 
[U-13C6] arginine (R) (C),  [U-13C6] histidine (H) (D), [U-13C4] aspartate (D) (E), [U-13C3] 
alanine (A) (F), [U-13C2] glycine (G) (G), [U-13C4] threonine (T) (H), [U-13C3] serine (S) 
(I), based on an analysis of triplicate 2D 1H-13C HSQC experiments.  Samples were 
assayed in either early (OD600=0.8-1.0) or late exponential (OD600=2.0-2.2) phases of 
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[U-13C6] arginine (R) (C),  [U-13C6] histidine (H) (D), [U-13C4] aspartate (D) (E), [U-13C3] 
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Thus, when S. aureus is growing on non-preferred carbon sources, an intact urea cycle 
is critical for the interconversion of arginine and proline. Since CDM does not contain a 
preferred carbon source, it is predicted that CcpA-repression would be alleviated and 
pathways to interconvert proline and arginine would be transcriptionally active. As 
predicted, proline synthesis was detected when 13C labeled arginine was added to CDM, 
however, arginine synthesis was not detected from 13C labeled proline (Fig. 3.7). 
Instead, ornithine was detected from 13C labeled proline suggesting, in addition to its use 
in glutamate synthesis, carbon from proline also enters the urea cycle. To further 
investigate arginine synthesis in CDM, JE2 and JE2 ccpA::tet were grown in media 
lacking either proline (CDM-P) or arginine (CDM-R). It was found that JE2 ccpA::tetL 
grew in both CDM-P and CDM-R, although growth was delayed in CDM-R (Fig 3.9). In 
addition, as predicted, JE2 wildtype grew in CDM-P, but a rocF mutant could not, 
suggesting that proline synthesis is fueled by arginine in CDM (Fig 3.9). However, 
unexpectedly, but consistent with the NMR data, JE2 could not grow in CDM-R 
suggesting that proline cannot serve as a precursor for arginine synthesis in the absence 
of a ccpA mutation.    
Histidine and aspartate 
Carbon derived from 13C histidine was primarily identified in glutamate 
metabolism and cysteine biosynthesis intermediates (Figure 3.7 and Figure 3.8D). 
Consistent with our amino acid analysis where histidine was catabolized more slowly 
than glutamate, proline, and arginine (Figure 3.2), significantly more metabolites 
(especially glutamate) were identified in the post-exponential phase as compared to the 
exponential phase. This observation suggests histidine is catabolized after proline and 
arginine are limited or depleted. 
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Figure 3.9.  Growth of S.aureus JE2 in CDM-P and CDM-R.  Growth of JE2 
rocF::NΣ, JE2 ccpA::tetL, and JE2 wildtype in CDM lacking proline (CDM-P) or 
arginine (CDM-R) (D).  Data represents means ± SEM of three biological replicates.  
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As the carbon backbone of aspartate enters central metabolism via oxaloacetate, it is 
not surprising that many metabolic intermediates derived from 13C aspartate were 
identified, including those that function in gluconeogenesis, the pentose phosphate 
pathway, nucleotide biosynthesis, amino acid biosynthesis, and glutamate metabolism 
(Figure 3.8E).  Indeed, as noted in Figure 3.4C, an aspA mutant, which is unable to 
synthesize oxaloacetate from aspartate, has an increased lag phase as compared to 
wildtype.    
Alanine, glycine, threonine, and serine 
The metabolic intermediates derived from these 13C glucogenic amino acids were 
very similar, reflecting their direct catabolism to pyruvate (Figure 3.7 and Figure 3.8F-I). 
Similar to other amino acids assayed, carbon derived from the glucogenic amino acids 
was identified in gluconeogenic intermediates, other amino acids, nucleotide 
biosynthesis, and glutamate. However, significantly more extracellular acetate was 
derived from alanine, threonine and serine as compared to other amino acids (Figure 
3.10A). Therefore, we hypothesized a bifurcation exists during amino acid catabolism 
where pyruvate generated from the glucogenic amino acids is primarily utilized to 
generate acetate and ATP via AckA and little carbon enters the TCA cycle via citrate 
synthase until acetate is consumed from the medium at six hours of growth. In addition, 
those amino acids that generate glutamate enter the TCA cycle at 2-oxoglutarate via 
GudB and serve as a carbon source to subsequently facilitate gluconeogenesis (Figure 
3.3). Although it is clear from the NMR data that the 13C glucogenic amino acids 
synthesize glutamate, this hypothesis predicts that mutations within gltA (citrate 
synthase), acnA (aconitase), and icd (isocitrate dehydrogenase) would not abrogate 
growth in contrast to mutations in other TCA cycle genes past the 2-oxoglutarate node. 
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Figure 3.10.  Extracellular acetate production via amino acid catabolism and 
intracellular citrate concentrations as an indicator of TCA cycle activity.  (A) 
Extracellular acetate detected following aerobic growth in CDM containing [U-13C4] 
aspartate (D), [U-13C5] glutamate (E), [U-13C5] proline (P), [U-13C6] histidine (H), [U-
13C6] arginine (R), [U-13C4] threonine (T), [U-13C3] serine (S), [U-13C3] alanine (A) or [U-
13C2] glycine (G).  NMR peak intensity was assessed in early exponential (early), mid 
exponential (middle) and late exponential (late) growth based on an analysis of 
triplicate 2D 1H-13C HSQC experiments. (B) Intracellular concentration of citrate as 
measured in early and post-exponential phases of growth in CDM (*p<.05).    
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Indeed, transposon mutants within gltA, acnA, and icd were grown in CDM, and, in 
contrast to the sucA, sdhA, and fumC TCA cycle mutants, growth was observed albeit 
with growth rate and yield defects (Figure 3.4R-T and Figure 3.3). In agreement with this 
premise, intracellular citrate concentrations, as an indicator of TCA cycle activity and 
entry of carbon into the TCA cycle, increased 3-fold during post-exponential growth in 
CDM as compared to exponential growth (Figure 3.10B).  Collectively, since we detected 
citrate in early exponential growth in CDM and we observed growth defects with the gltA, 
icd, and acnA mutants even before acetate is depleted from the medium (6 hours of 
growth; Figure 3.1), these data suggest that the TCA cycle is active throughout growth in 
CDM, but carbon flux is reduced through the TCA cycle and is instead routed to acetate 
when amino acids that generate pyruvate are present in the medium. Once these amino 
acids are depleted (primarily serine, threonine and alanine), acetate is consumed and 
enters the TCA cycle to generate 2-oxoglutarate.  
Respiration is reduced, but required for viability, during growth of S. aureus in 
CDM  
As an ackA mutant was unable to grow in CDM, we hypothesized that the ATP 
generated by acetate kinase is critical for growth under these conditions. We reasoned 
that the two NADH generated by 2-oxoglutarate dehydrogenase (SucA) and malate 
quinone oxidoreductase (Mqo1) are utilized during gluconeogenesis to regenerate NAD+ 
and maintain redox balance. Thus, the net NADH may be reduced during growth in CDM 
below levels needed to drive oxidative phosphorylation from the staphylococcal 
NADH:quinone oxidoreductase. Therefore, experiments were designed to determine if 
respiration is reduced during growth in CDM as compared to TSB or CDM containing 14 
mM glucose (CDMG). The relative rate of oxygen consumption during growth in CDM 
was approximately 50% of the rate in TSB; and the rate was significantly lower than that 
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detected in CDMG (Figure 3.11A). Consistent with these observations, the relative 
intracellular ATP concentration during growth in CDM was 12% of the concentration in 
TSB (Figure 3.11B). Collectively, these data suggest that growth in CDM yields 
significantly decreased respiratory activity and coincident ATP synthesis.  
S. aureus contains a branched respiratory chain and has at least two terminal 
menaquinol oxidases, QoxABCD (cytochrome aa3 oxidase) (4, 108) and CydAB 
(cytochrome bd oxidase) (109). To date, the presence of a third terminal oxidase, a 
cytochrome bo oxidase, is unclear (110). Respiratory complexes that feed the 
menaquinone pool include succinate dehydrogenase (Sdh) (111), lactate quinone 
oxidoreductase (Lqo) (10, 11, 112), and malate quinone oxidoreductase (Mqo) (10, 11). 
Furthermore, S. aureus does not contain a complex I NADH oxidoreductase, but instead 
encodes a type 2 non-electrogenic NADH:quinone oxidoreductase (Ndh2) that may be 
linked to an NuoL-like protein MpsA that functions to translocate cations, but has no 
NADH binding capability (113). The lack of growth demonstrated by a succinate 
dehydrogenase mutant (Figure 3.3 and Figure 3.4K) and the decreased ATP 
concentration and oxygen consumption noted during growth in CDM led us to address 
the importance of the electron transport chain during growth in CDM. Transposon 
mutants deficient in NADH:quinone oxidoreductase  (nrd; SAUSA300_0844), and quinol 
oxidase (qox) were cultured in CDM, however, both the nrd and qox mutants were 
unable to grow aerobically in CDM (Figure 3.12A). Furthermore, growth of S. aureus was 
halted in CDM 
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Figure 3.11.  Metabolic indicators of JE2 growth in CDM, TSB or CDMG. Relative 
rate of oxygen consumption (A) and ATP concentration (B) following growth of JE2 in 
CDM, CDMG or TSB.  Rates of JE2 grown in TSB were set at 100%. Samples for (A) 
and (B) were collected in mid-exponential phase (***p<.001; ****p<.0001).    
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when the ATP synthase inhibitor DCCD was added to the medium in early exponential 
phase (Figure 3.12B). Conversely, DCCD had little effect on growth in CDMG or TSB 
(Figure 3.12C and 3.12D). Collectively, these experiments suggest that ATP generated 
via both substrate level phosphorylation and oxidative phosphorylation is required for 
growth in CDM and the importance of the PTA-AckA pathway under these conditions is 
most likely linked to the reduced rate of respiration.  
Growth of gudB and ackA mutants in CDM is impaired under anaerobic growth. 
The infection model proposed by Spahich and colleagues suggests that S. 
aureus growing under mild NO stress within an anoxic, glucose-depleted abscess 
requires both lactate and peptides. Thus, we assessed whether gudB and ackA were 
also required for growth in CDM under anaerobic growth conditions. JE2 was grown in 
CDM with or without lactate and/or nitrate, which was used as a terminal electron 
acceptor. These experiments demonstrated that enhanced growth was only observed in 
CDM containing lactate and nitrate as previously described (10, 11) (Figure 3.13A). 
Thus, JE2 gudB::NΣ and JE2 ackA were grown in CDM containing lactate and nitrate. 
As predicted, no growth was observed for either of these mutants (Figure 3.13B).  
S. aureus does not utilize proline or arginine during growth in CDMG.  
During our initial studies with growth in CDM, we found that several differences 
were noted if 14 mM glucose was added to the medium. First, aerobic growth of S. 
aureus JE2 in CDMG reached an OD600 maximum of approximately 5.5 following 6 hours 
of growth at which time glucose was exhausted from the medium (Figure 3.14A). In 
contrast to growth in TSB (106) and CDM (Figure 3.1), acetate was not completely 
consumed from CDMG suggesting that growth arrest and subsequent acetate oxidation 
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Figure 3.12.  Importance of aerobic respiration during growth in CDM.  Aerobic 
growth of JE2, JE2 qoxB::NΣ, and JE2 nrd2::NΣ in CDM (A).  Growth of JE2 in CDM 
following the addition of the ATP synthase inhibitor DCCD in early exponential phase 
(B). Growth of JE2 in CDMG following the addition of the ATP synthase inhibitor 
DCCD in early exponential phase (C). Growth of JE2 in TSB following the addition of 
the ATP synthase inhibitor DCCD in early exponential phase (D). Data represents 




Figure 3.13.  Importance of anaerobic respiration during growth in CDM. 
Anaerobic growth (24 hour) of JE2 in CDM containing either 3 mM sodium 
nitrate or 0.5% lactate (CDML) (A).  Anaerobic growth (24 hour) of JE2, JE2 
gudB::NΣ, and JE2 ackA::NΣ grown in CDM containing sodium nitrate (3 mM) 




via the TCA cycle was halted due to depletion of critical amino acids or other C4/C5 
compounds as previously discussed, although the exact mechanisms are not clear 
(Figure 3.14A) (111). Amino acid analysis of spent medium demonstrated that aspartate, 
glutamate, lysine and the glucogenic amino acids alanine, serine, glycine and threonine 
were rapidly depleted from the medium (Figure 3.15). However, the remaining amino 
acids, including arginine, histidine and proline that are known to generate glutamate 
during growth in CDM, were incompletely utilized following 12 hours of growth. In fact, a 
mutation in gudB had little effect on growth in CDMG in contrast to that observed with 
growth in CDM (Figure 3.14B). As discussed previously, investigations have shown that 
arginine and proline catabolism is repressed via CcpA and carbon catabolite repression 
(5, 41). However, following glucose consumption at 6 hours of growth, rapid arginine 
and/or proline depletion was not observed. Furthermore, no growth was observed in 
CDMG when proline (CDMG-P) or arginine (CDMG-R) was subtracted from the medium 
(Figure 3.14C). In contrast, the lack of glutamate in CDMG (CDMG-E) did not result in a 
significant growth defect (Figure 3.14C). NMR analysis using 13C6-glucose confirmed that 
glucose was metabolized to synthesize glutamate, thus facilitating growth in CDMG-E 
(Figure 3.16). However, almost undetectable levels of 13C labeled arginine or proline 
were detected during growth with CDMG containing 13C6-glucose confirming previous 
data demonstrating that arginine and proline need to be acquired from exogenous 
sources when S. aureus grows on preferred carbon sources such as glucose (5, 41). 
Collectively, these data suggest that growth of S. aureus in CDMG results in rapid 
utilization of glucose serine, threonine, alanine, glycine, glutamate, lysine and aspartate. 
However, proline and arginine, key amino acids that fuel glutamate synthesis when  
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Figure 3.14. Growth of S. aureus JE2 in CDMG. Aerobic growth of JE2 in 
CDMG displaying glucose consumption and acetate, ammonia, and lactate 
production (A).  Growth of JE2 and JE2 gudB::NΣ in CDMG (B) and JE2 in CDMG, 
CDMG lacking arginine (CDMG-R), CDMG lacking glutamate (CDMG-E) and CDMG 




Figure 3.15.  Amino acid consumption of JE2 following growth in CDMG.  JE2 
was grown aerobically in CDMG and amino acid concentrations (mM) were measured 




Figure 3.16.  NMR Peak intensity of CDMG supplemented with 13C labeled 
glucose.  Metabolites derived from [U-13C6] glucose following aerobic growth in 
CDMG based on an analysis of triplicate 2D 1H-13C HSQC experiments..  Metabolites 
were assayed in early, mid or late exponential growth.          
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grown in CDM, are not extracted from the medium.  Furthermore, it is unclear how lysine 
is rapidly utilized during growth in CDMG as pathways that function to catabolize lysine 
were not identified in S. aureus FPR3757 (Table 1.1).    
Discussion   
  Our knowledge of how S. aureus proliferates within multiple niches of the host is 
limited. Nevertheless, recent studies have found that S. aureus can adapt to changing 
carbon sources and oxygen availability found within specific organ systems. For 
example, Hammer and colleagues determined that S. aureus defective in aerobic 
respiration were unable to mediate infection in the heart or liver, but colonization and 
abscess formation in the kidney was unaffected (4). Complementing these findings, S. 
aureus defective in anaerobic fermentation were less virulent than wildtype in a mouse 
model of kidney infection (3). Additionally, mutants defective in CcpA are less effective at 
infecting the liver where glucose is abundant, but infection burden in the kidney is not 
affected (5). Thus, taken together, these data suggest that S. aureus uses distinct 
central metabolic pathways to adapt to different carbon or oxygen sources that are 
available within the organ system or site of infection.  
An elegant model has emerged demonstrating how S. aureus survives within a 
staphylococcal abscess (10). The antimicrobial action of NO occurs at multiple nodes of 
central metabolism including the TCA cycle and respiration. However, the NO 
concentration at the center of staphylococcal abscesses is thought to be below 1 µM 
allowing respiration and other metabolic processes to be functional (103, 114). 
Furthermore, glucose is depleted due to phagocytic cell activity whereas lactate 
concentration is abundant due to excretion during staphylococcal growth (10, 104). 
Thus, the major carbon sources for S. aureus at the center of abcesses are lactate and 
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peptides. Lactate is utilized via LQO that generates pyruvate and subsequently acetate 
via Pta/AckA whereas, peptides provide a carbon source for gluconeogenesis. The goal 
of this manuscript was to assess amino acid catabolism and to determine the importance 
of particular amino acid catabolic pathways during growth without glucose or other 
preferred carbon sources. 
Bioinformatic analyses of the USA300 LAC (50) and other staphylococcal 
genomes in public databases found that S. aureus has the potential ability to catabolize 
11 amino acids to either pyruvate, oxaloacetate, or 2-oxoglutarate (Table 1.1). Growth in 
CDM and subsequent amino acid analysis verified these predictions for 10 of the 11 
amino acids. The lone amino acid not catabolized, but predicted based on bioinformatics 
analyses, was cysteine. This may be because CDM contains MgSO4 as a sulfur source. 
It is well established that S. aureus cannot utilize sulfate, sulfite, or sulfonates as the 
source of sulfur in cysteine biosynthesis whereas it can use thiosulfate, sulfide, or 
glutathione (115). Thus, we predict that a feedback mechanism exists for repressing 
cysteine catabolism if an appropriate sulfur source for cysteine synthesis is not present.  
In addition, we observed that lysine was catabolized when S. aureus was grown in 
CDMG, but not CDM.  Some species are known to ferment lysine to acetate (116), but 
metabolic pathways to perform this function are not immediately recognized in the S. 
aureus genome.    
Glutamate is the major amino donor for most anabolic enzymatic reactions and 
yet also functions as a key intermediate in carbon metabolism (12, 25). Our results 
suggest that glutamate, and those amino acids that can be converted into glutamate, 
serve as central carbon sources to facilitate growth in media lacking a preferred carbon 
source such as glucose. First, glutamate dehydrogenase (GudB), an enzyme that 
catalyzes the conversion of glutamate to 2-oxoglutarate, is required for growth in CDM. 
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In addition, all enzymes (excluding Mqo1, which is rescued by anaplerotic reactions 
generating oxaloacetate) that function in the TCA cycle downstream of 2-oxoglutarate 
are required including phosphoenolpyruvate carboxykinase (PckA) that generates PEP 
from oxaloacetate. Thus, glutamate fuels the TCA cycle allowing subsequent 
gluconeogenic reactions and presumably serves as the major amino group donor to 
cellular reactions.  
Second, although NMR analysis found that 13C carbon from all of the amino acids 
tested eventually was incorporated into glutamate, only mutations in those genes that 
code for enzymes that function to generate glutamate from proline or histidine resulted in 
a significant growth defect. Outside of arginine, all other amino acids must generate 
glutamate via the TCA cycle and glutamate synthase (GOGAT). However, a mutation in 
gltB (encoding large subunit of GOGAT; Figure 3.4U) conferred no growth defect in 
CDM suggesting the importance of glutamate synthesis from other amino acids besides 
proline and histidine is minimal. As indicated by NMR, arginine can also directly be 
converted to glutamate by the arginase pathway (RocF-RocD-RocA) (Figure 3.3). 
Alternatively, independent of RocF, arginine deiminase (57) can synthesize ornithine 
from arginine, which can then be catabolized to glutamate via RocD and RocA. 
However, individual rocF (Figure 3.4E) and arcA1/arcA2 (Figure 3.4Q) mutants did not 
have a growth defect in CDM whereas a rocF/arcA1/arcA2 (Figure 3.4V) mutant only 
had a post-exponential growth defect suggesting that arginine catabolism does not 
significantly contribute to exponential growth.  However, it was surprising to note that a 
rocD mutant had a similar growth phenotype in CDM as the rocA mutant (Figure 3.4W-
X); RocD converts ornithine, which can be synthesized from arginine via RocF, to P5C 
(Figure 3.3).  Since the rocF (Figure 3.4E) mutant did not have a significant growth 
defect, one would predict that a rocD mutant would phenocopy a rocF mutant.  S. aureus 
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also encodes a nitric oxide synthase (nos), which catalyzes the formation of citrulline 
from arginine generating NO (62).  Thus, it is possible that arginine is primarily 
catabolized via NOS and not arginase or arginine deiminase during growth in CDM, but 
this is currently unknown.   Nevertheless, complementing these genetic findings, 
comparison of NMR peak intensities suggested that glutamate synthesis via proline was 
approximately five-times and six-times that synthesized from arginine in exponential and 
post-exponential phase, respectively, and approximately five-times and 2.5-times that 
synthesized from histidine in exponential and post-exponential phase, respectively 
(Figure 3.8A-D). Thus, as our NMR and amino acid utilization data demonstrate, 
histidine is utilized after proline is limiting. Collectively, our data suggest that proline is 
the primary substrate for glutamate synthesis during exponential phase and histidine is 
utilized once proline is limiting. Furthermore, arginine is a minor source of glutamate 









Bacterial survival depends on the ability of the organism to sense and respond to 
environmental stresses such as temperature and pH fluctuations, as well as alterations 
in nutritional availability and quality.  As carbon and energy sources within specific host 
niches vary, bacteria must be able to efficiently utilize available nutrients to survive.  
Pathogenic bacteria exhibit a wide range of central metabolic capabilities, allowing the 
bacteria to persist within the human host even when stressful environments are 
encountered.  Global regulators such as CcpA and CodY are responsible for modulating 
the metabolic response to changing environmental conditions, assuring that nutrient and 
energy requirements are fulfilled (117, 118).    
While commonly thought of as the building blocks of proteins, amino acids can 
be utilized as substrates for a variety of bacterial cell processes depending on the 
nutrient availability of the surrounding environments (43).  It has been established in 
several gram-positive bacteria that arginine catabolism via ADI generates ammonia for 
pH homeostasis and ATP to fuel cell processes (15, 16, 57).  B. subtilis has the ability to 
use amino acids, such as arginine and proline, as sole carbon or nitrogen sources in 
nutrient-limiting conditions (32, 44-46, 48).  Indeed, in the previous chapter it was 
demonstrated that S. aureus utilizes proline, histidine, and arginine as substrates for 
glutamate synthesis in the absence of glucose, therefore providing carbon for TCA cycle 
activity and gluconeogenesis.  
CcpA Regulation 
Because of the diverse capabilities of amino acids, their catabolic pathways are 
under the control of multiple layers of regulation.  Regulation of amino acid catabolism 
ensures the transcription of only those genes necessary for the efficient utilization of 
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available nutrient sources, which avoids wasting energy by synthesizing unnecessary 
macromolecules. Most bacteria can use various compounds as carbon sources, 
including amino acids.  Carbon catabolite regulation ensures that secondary carbon 
sources are not utilized when preferred carbon sources, such as glucose, are in 
abundance, thus, preventing energy expenditure as a result of the expression and 
activity of unnecessary catabolic systems (1, 119, 120).   In pathogenic bacteria, carbon 
catabolite repression has also been linked to virulence factor expression as the proteins 
encoded by virulence genes are often involved in nutrient acquisition/utilization (120).   
The catabolite regulator, CcpA, is highly conserved among low-G+C, gram-
positive bacteria including B. subtilis and S. aureus (121).  When preferred carbon 
sources such as glucose are transported into the cell, the accumulation of ATP and the 
glycolytic intermediates fructose-1,6-bisphosphate (FBP) and glucose-6-phosphate (Glu-
6-P) leads to the phosphorylation of the HPrK kinase/phosphorylase at Ser-46 (122-
124).  Phosphorylation at this position results in an interaction with CcpA, which in turn 
binds to catabolite responsive elements (cre) within promoter/operator regions, thereby 
enhancing or repressing expression of the target gene (125-127).  In B. subtilis, more 
than 100 genes that function in carbon acquisition and metabolism are CcpA regulated 
(12).  Similarly, the CcpA regulon in S. aureus spans hundreds of genes involved in 
carbon metabolism.  Several genes regulated by CcpA are involved in amino acid 
metabolism, including argGH, rocD, rocF, rocA, and ald (5, 37, 41, 128).  Furthermore, 
CcpA can also directly or indirectly regulate virulence gene expression in S. aureus (83, 





 CodY is also a highly conserved global regulator among low-G+C gram-positive 
bacteria, responding to nutritional availability (129). CodY is a DNA-binding protein 
responding to intracellular concentrations of two classes of metabolites: the branched-
chain amino acids isoleucine, leucine, and valine (BCAAs) and GTP (130, 131).  BCAAs 
bind to the GAF domain of CodY and induce a conformational change within CodY, 
affecting the C-terminal DNA binding domain and increasing the affinity of CodY for its 
DNA-binding sequence, thereby repressing or activating target genes (132).  When 
nutrients become limiting, decreasing intracellular BCAA pools signal a transition from 
exponential- to stationary-phase growth and result in a decrease in affinity with the CodY 
GAF domain, which in turn decreases the affinity of CodY-DNA binding.  Similarly, CodY 
senses the energy status of the cell via interaction with GTP, sensing intracellular GTP 
concentrations.  However, the location of the GTP binding site of the S. aureus CodY 
has not been identified (133). 
 In S. aureus, CodY directly or indirectly controls the expression of over 200 
genes, including those involved in metabolism and virulence, thus linking nutrient 
availability to virulence.   CodY directly regulates genes involved in central and amino 
acid metabolism during nutrient limitation, prioritizing nutrient uptake and biosynthesis to 
ensure survival.  Indeed, genes involved in carbon overflow metabolism and the TCA 
cycle, such as pyruvate carboxylase and 2-oxoglutarate dehydrogenase, were repressed 
during nutrient-rich, exponential-phase growth.  Similarly, CodY repressed several amino 
acid biosynthetic pathways, including glutamate synthase, in nutrient-rich conditions 
(134).  Regulation via CodY allows the organism to scavenge available nutrients for 
energy and biomass production, before diverting carbon and nitrogen towards 
biosynthesis of essential building blocks such as amino acids (135).   In this chapter, we 
	 86	
utilized genetic and transcriptional studies to investigate the regulation of glutamate 
biosynthesis via the substrates proline, arginine, and histidine in S. aureus USA300 JE2.   
Results 
putA, rocD, hutU, rocA, gudB, and rocF are regulated via carbon catabolite repression 
and CcpA.  
The studies described in chapter 3 suggest that proline and arginine catabolism 
is dependent upon carbon catabolite repression. Indeed, previous studies demonstrated 
that the interconversion of proline and arginine is repressed via CcpA at rocF, rocD, and 
putA in the presence of glucose (5, 41) indicating those amino acids that can be 
converted to glutamate can be used as alternative carbon sources. Therefore, it was 
hypothesized that the conversion of histidine to glutamate in addition to the conversion 
of arginine and proline to glutamate via pyrolline-5 carboxylate and RocA and the 
subsequent conversion of glutamate to 2-oxoglutarate via GudB would also be CcpA 
repressed as these reactions would only be necessary if there were no other preferred 
carbon sources available (Figure 3.3). Therefore, northern blots were utilized to assess 
transcription of putA, rocD, hutU, rocA, gudB, and rocF in both JE2 and JE2 ccpA::tetL 
following growth in CDMG and CDM. These experiments revealed that putA, rocD, rocA, 
gudB, and rocF transcription was induced after glucose was exhausted from CDMG 
(post-exponential growth; Figure 4.1A).  In addition, as expected, transcription of putA, 
rocD, rocA, gudB, and rocF in exponential growth was ccpA-dependent as transcription 
was detected in JE2 ccpA::tetL following exponential growth in CDMG (Figure 4.1A). 
Furthermore, transcription of putA, rocD, rocA, gudB, and rocF was detected during 
exponential growth in CDM, which was expected as CDM contains only amino acids as 
carbon sources (Figure 4.1B).  Therefore, repression by CcpA should be alleviated.  
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Figure 4.1.  Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and 
hutU following growth in CDMG and CDM.  Northern analysis was 
performed with RNA isolated from exponential (early) and post-exponential 
(late) phases of growth (both CDMG (A) and CDM (B)) from JE2 and JE2 
ccpA::tetL.  C. Northern analysis of hutU transcription in JE2 from 8 hr to 10 hr 
of growth.  JE2 ccpA::tetL late RNA was used as a positive control. Equal 
loading of RNA was ensured via staining of the RNA gel with ethidium bromide 
and visualization of the 16s and 23s rRNA (data not shown).   
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Transcription of hutU, however, was only detected in JE2 ccpA::tetL in 
exponential phase but not in exponential phase of wildtype JE2.  Based on the NMR and 
amino acid utilization data (Figure 3.7 and 3.2), we predicted that hutU transcript would 
be detected in post-exponential phase following proline and arginine depletion in CDM.  
Indeed, hutU transcription was detected by 12 hours of growth in wildtype JE2 (Figure 
4.1C).  In addition, hutU transcripts were not detected in CDMG, even in the ccpA 
mutant.  These data may suggest that growth arrest occurs in CDMG before potentially 
multiple regulatory networks induce hutU expression.  Indeed, histidine catabolism in B. 
subtilis is regulated via both CcpA and CodY (70, 136).  Collectively, these data 
demonstrate that pathways that function to fuel glutamate catabolism, and gudB, which 
fuels the TCA cycle from glutamate, are all regulated by CcpA and are induced only 
when glucose is not present in the medium.   
CodY regulates proline, arginine, and histidine utilization pathways 
 Previous studies of CodY regulation in S. aureus have determined that over 200 
genes are directly or indirectly regulated by CodY, including many of those involved in 
amino acid metabolism and transport (134).  Recent studies from Waters and colleagues 
demonstrated that regulation via CodY in S. aureus allows for prioritization of nutrient 
uptake and biosynthesis during growth with limited or varying carbon and nitrogen 
sources.  They constructed codY allelic exchange mutants with varying degrees CodY 
activity due to point mutations at conserved arginine and glycine residues within the ILV-
binding pocket.  These studies demonstrated that amino acid uptake genes were 
generally more sensitive to changes in CodY activity than their cognate biosynthesis 
genes, allowing the pathogen to scavenge the surrounding environment for nutrients 
before utilizing carbon, nitrogen, and energy for their biosynthesis.  Furthermore, these 
studies demonstrated that not all biosynthesis pathways are regulated at the same level 
	 89	
of CodY activity.  For example, although lysine, methionine, and threonine are all 
synthesized from aspartate, lysine and methionine biosynthetic genes were expressed 
with only minor reductions in CodY activity compared to threonine biosynthetic genes 
(135).  Lysine can be utilized as a substrate for peptidoglycan synthesis (137, 138); 
therefore it is possible that minor changes in CodY activity affects lysine biosynthesis to 
support both protein production and peptidoglycan synthesis (135).  The sensitivity of 
methionine biosynthesis to CodY activity could reflect adaptation of S. aureus to its host, 
as methionine is limited in physiological fluids (135, 139, 140).  Collectively, these 
studies demonstrate a spectrum of CodY activity regulates S. aureus metabolism, 
prioritizing nutrient uptake and biosynthesis in nutrient depleted environments.   
The studies described in the previous chapter suggest that when grown in the absence 
of glucose, S. aureus utilizes glutamate, and those amino acids that can be utilized as 
substrates for glutamate synthesis (proline, arginine, and hisitidine), as carbon sources 
to fuel TCA cycle activity and gluconeogenesis. Growth and NMR studies demonstrated 
that proline, arginine, and histidine all serve as substrates for glutamate synthesis in 
glucose limiting conditions (Figure 3.6 and 3.7). Proline utilization via PutA and RocA 
appeared to be the major source of glutamate, as the putA and rocA transposon mutants 
had significant growth yield defects when grown in CDM lacking glutamate (CDM-E) 
compared to wild type JE2; whereas mutations in the pathways utilizing arginine (rocF) 
and histidine (hutU) had only moderate growth defects compared to wild type JE2 grown 
in CDM-E.  Furthermore, the relative amount of glutamate generated from proline was 
approximately five-fold greater than the amount generated from arginine (Figure 3.8).  
As recent studies have suggested that CodY regulates preferential uptake and utilization 
of nutrients (135), we hypothesized that CodY would function to regulate proline, 
arginine, and histidine utilization as substrates for glutamate synthesis when grown in 
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carbon limiting conditions.  Indeed, the codY transposon mutant had significant growth 
defects when grown in CDM and CDM-E, suggesting that CodY positively affects the 
transcription of glutamate synthesis pathways (Figure 4.2).  Therefore, northern blots 
were utilized to assess the transcription of rocA, putA, rocD, hutU, rocF, and gudB in 
both JE2 and JE2 codY::ΝΣ following growth in CDM.  These experiments revealed a 
decrease in induction of putA and rocA in the codY mutant when compared to wild type 
JE2 during exponential-growth in CDM (Figure 4.3A).  Furthermore, northern blot 
assessment of the transcription of these genes during growth in CDMG demonstrated a 
complete loss of not only putA and rocA transcription, but also a loss of rocD and gudB 
transcription, following glucose exhaustion in the codY mutant when compared to wild 
type JE2 (Figure 4.3B).  These data suggest that in the absence of CcpA repression, 
CodY activity positively regulates transcription of genes involved in the synthesis of 
glutamate via proline and arginine catabolism.   
As previously described, hutU transcription was predicted to occur in JE2 during 
stationary phase following proline and arginine depletion in CDM, however hutU 
transcription was only detected during exponential growth in a ccpA mutant.  We 
hypothesized CodY would also be functioning to regulate hut transcription during growth 
in CDM, as both CcpA and CodY function to repress histidine catabolism in B. subtilis.  
Indeed, hutU transcripts were detected during post-exponential growth in JE2 codY::ΝΣ, 
suggesting that both CodY and CcpA function to repress histidine catabolism in S. 
aureus (Figure 4.3A).  Collectively, these data suggest that when preferred carbon 
sources like glucose are limiting and CcpA repression is alleviated, CodY activity 
regulates glutamate synthesis via induction of proline and arginine catabolic genes, 
while repressing histidine catabolism.  
Regulation via the arginine transcriptional regulators ArgR1, ArgR2, and AhrC 
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Figure 4.2.  Growth in CDM-E. (A)  Aerobic growth of JE2 and JE2 codY::NΣ 
in CDM-E.   (B)  Growth of JE2 and JE2 argR1::NΣ CDM-E. Data represents 






Figure 4.3.  Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and 
hutU in S. aureus JE2 and JE2 codY::ΝΣ.  Northern analysis was performed 
with RNA isolated from exponential (early) and post-exponential (late) phases 
of growth in CDM (A) and CDMG (B) from JE2 and JE2 codY::ΝΣ.  Equal 
loading of RNA was ensured via staining of the RNA gel with ethidium bromide 
and visualization of the 16s and 23s rRNA (data not shown).   
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In B. subtilis, the expression of both arginine and proline catabolic genes are 
controlled by multiple transcriptional regulators, sensing several environmental cues.  In 
addition to regulation via CcpA sensing the availability of glucose and CodY sensing the 
nutritional status of the cell through assessments of BCAA levels, as well as the energy 
status of the cell via intracellular GTP concentrations, B. subtilis encodes regulators that 
sense the availability of specific amino acids.  Proline can serve as the sole carbon or 
nitrogen source in B. subtilis through utilization of the putBCP operon.  The 
transcriptional activator, PutR, induces the expression of this operon in the presence of 
proline.  However, CodY activity will repress putBCP expression by displacing PutR (46).  
B. subtilis can also utilize arginine as a sole carbon or nitrogen source via the arginase 
pathway (rocABC and rocDEF operons), which is induced via the positive transcriptional 
regulator RocR when in the presence of arginine, ornithine, citrulline, or proline  (32, 48).  
A second regulatory protein, AhrC, also acts a positive regulator of these operons in the 
presence of arginine, while repressing the arginine biosynthetic arg operon (141). 
 As previously discussed, the S. aureus genome does not encode orthologous 
putR or rocR genes, however, it does encode the arginine transcriptional regulator, 
ahrC. Arginine transcriptional regulation was first described in Esherichia coli, in which 
the transcriptional regulator, ArgR, repressed the transcription of the arginine 
biosynthetic arg operon.  In the presence of arginine, ArgR binds to one or more 18-bp 
palindromic sequences referred to as ARG boxes, repressing transcription of arg genes 
(142).  In B. subtilis, the ArgR-type regulator, AhrC, was shown to not only repress 
transcription of arginine biosynthesis but also activate arginine catabolism via the 
arginase pathway in the presence of arginine (143).  In Lactococcus lactis, another 
gram-positive bacterium, both ArgR and AhrC have been shown to regulate arginine 
metabolism.  Here, in the absence of arginine ArgR has a higher affinity for the promoter 
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of the arginine catabolic arc operon than it does for the biosynthetic arg operon, possibly 
due to additional ARG box binding sites within the arc promoter.  This prevents arginine 
degradation via the ADI pathway, while allowing for de novo arginine synthesis via the 
arg operon.  The addition of arginine results in the formation of an AhrC-ArgR protein 
complex, with high affinity for the ARG box binding sites within the promoter of the arg 
promoter.  ArgR repression of the arc promoter is alleviated as it complexes with AhrC, 
repressing the expression of arginine biosynthetic genes and allowing for arginine 
catabolism via the ADI pathway (54).   
 S. aureus USA300 JE2 has three ArgR-type transcriptional regulators, AhrC, 
ArgR1, and ArgR2.  The transcriptional regulator AhrC, which shares 61% amino acid 
sequence homology to the B. subtilis AhrC protein, is encoded by ahrC on the 
chromosome in an operon with the DNA recombination gene, recN. ArgR1 and ArgR2 
are encoded by the genes, argR1 and argR2, which are monocistronic units of the two 
ADI operons found within the S. aureus USA300 JE2 genome.   The native ADI operon 
contains the gene argR1, encoding the native arginine transcriptional regulator, ArgR1.  
While the acquired arginine catabolic mobile element (ACME) encodes a second ADI 
operon, and therefore a second arginine transcriptional regulator, ArgR2 (Figure 4.4) 
(50).   As AhrC and ArgR function to regulate utilization of arginine as alternative carbon 
and nitrogen sources in other gram-positive bacteria, we hypothesized they may have 
similar functions in S. aureus when grown in CDM and utilizing amino acids as carbon 
sources.  Northern blots were utilized to assess transcription of putA, rocD, hutU, rocA, 
gudB, and rocF in JE2, the transposon mutants JE2 argR1::ΝΣ and JE2 argR2::ΝΣ, and 
JE2 ΔahrC following growth in CDM (Figure 4.5, 4.7, and 4.8).  An in-frame, markerless 
deletion was constructed in JE2 ΔahrC to avoid any polar mutations with recN. These 
experiments revealed that in S. aureus, the arginine repressor ArgR1 functions to 
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Figure 4.4  Comparison of native (argR1 – arcR1) and acquired (argR2 – 
arcC2) ADI operons and arginine transcriptional  regulators (argR1, 
argR2, and ahrC).  Percentage of amino acid identity between genes of the 
native and acquired ADI operon and between all three arginine transcriptional 





Figure 4.5.  Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and 
hutU in S. aureus JE2 and JE2 argR1::ΝΣ.  Northern analysis was 
performed with RNA isolated from exponential (early) and post-exponential 
(late) phases of growth in CDM (A) and CDMG (B) from JE2 and JE2 
argR1::ΝΣ.  Equal loading of RNA was ensured via staining of the RNA gel 
with ethidium bromide and visualization of the 16s and 23s rRNA (data not 
shown).   
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regulate proline catabolism via putA transcription as JE2 argR1::ΝΣ had decreased 
expression of putA during early-exponential growth when compared to wild type JE2 
(Figure 4.5A).  Indeed, a mutation in argR1 results in a significant growth yield defect, 
similar to a codY mutant, compared to wild type JE2 when grown in CDM-E (Figure 4.6).  
Furthermore, putA transcription was also decreased in this mutant during post-
exponential growth in CDMG (Figure 4.5B).  Suggesting that in the absence of carbon 
catabolite repression, ArgR1 can function to activate proline catabolism.  
 As argR2 is an acquired arginine repressor, not native to the chromosome, we 
expected to see minimal effects on growth and gene expression in the argR2 transposon 
mutant when grown in CDM.  The argR2 mutant had a similar growth phenotype as JE2 
when grown in CDM, however, a moderate growth yield defect was observed compared 
to JE2 when grown in CDM-E, suggesting regulation of glutamate synthesis via ArgR2.  
Northern blot analysis revealed increased rocF transcription during early-exponential 
growth and delayed induction of rocA transcription in the argR2 mutant compared to wild 
type JE2 when grown in CDM (Figure 4.7).  While in the ahrC mutant, rocA and rocD 
had increased expression during early-exponential growth when compared to wild type 
JE2, suggesting ArgR2 and AhrC are both functioning to regulate arginine catabolic 
pathways (Figure 4.8).  It is also worth noting that in an ahrC mutant, hutU transcription 
was observed during late-exponential growth, similar to what was seen in the codY 
mutant, indicating AhrC activity also regulates histidine catabolism (Figure 4.3A).     
Discussion 
 Bacteria are able to adapt efficiently to a wide range of nutritional environments 
through the use of regulatory systems linking nutritional availability to gene expression.  
B. subtilis integrates the activities of several global regulators, including CcpA and CodY,  
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Figure 4.6.  Growth of S. aureus JE2 an arginine transcriptional regulators in 
CDM and CDM-E. Aerobic growth of JE2 argR1::NΣ, JE2 argR2::NΣ, and JE2 
ΔahrC in CDM (A) and CDM-E (B) in comparison to wild type JE2.  Data represents 





Figure 4.7.  Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and hutU 
in S. aureus JE2 and JE2 argR2::ΝΣ.  Northern analysis was performed with RNA 
isolated from exponential (early) and post-exponential (late) phases of growth in 
CDM  (A) and CDMG (B) from JE2 and JE2 argR2::ΝΣ.  Equal loading of RNA was 
ensured via staining of the RNA gel with ethidium bromide and visualization of the 




Figure 4.8.  Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and hutU 
in S. aureus JE2 and JE2 ΔahrC.  Northern analysis was performed with RNA 
isolated from exponential (early) and post-exponential (late) phases of growth in 
CDM  (A) and CDMG (B) from JE2 and JE2 ΔahrC .  Equal loading of RNA was 
ensured via staining of the RNA gel with ethidium bromide and visualization of the 
16s and 23s rRNA (data not shown).   
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to control gene expression according to what nutrients are available (12).  Pathogenic 
bacteria often contend with its host restricting nutrient availability, thus they have 
evolved or acquired virulence factors that aid in nutrient acquisition through host tissue 
destruction.  Often, these bacteria utilize the same regulators of metabolism as 
regulators of virulence, coordinating nutrient availability with virulence.  Coordination of 
regulation in this way reserves expression of destructive virulence factors for nutrient 
limiting environments (12, 117).  In S. aureus, virulence and metabolic gene expression 
have been linked to both CodY and CcpA activity, allowing this pathogen to maximize 
the limited nutritional resources available within its host.  Li et al. demonstrated a link 
between carbon catabolite repression via CcpA and virulence, as a ccpA mutant 
demonstrated attenuated virulence in a liver abscess model of infection compared to 
wild type, indicating the regulation of carbon source utilization is important during 
pathogenesis (5).  Furthermore, S. aureus CodY has been shown to regulate gene 
expression through a spectrum of CodY activity.  As nutrients begin to be depleted from 
the environment, CodY sequentially activates the expression of virulence genes 
(typically via loss of repression) encoding proteins that destruct host tissues, as wells as 
nutrient scavenging/metabolism genes allowing the bacterium to acquire and utilize the 
available nutrients found within the degraded tissue (135).      
Understanding the interwoven metabolic and regulatory networks within S. 
aureus in their entirety requires large data sets and a systems biology approach; 
however, defining individual regulatory nodes provides useful information as to when 
these metabolic networks may be functional during pathogenesis.  We have previously 
described an emerging model of S. aureus abscess formation where it is hypothesized 
that viable cells within the abscess must utilize lactate, peptides, and free amino acids 
as carbon and energy sources (10, 11, 104).  In our assessment of amino acid 
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catabolism we determined that S. aureus utilizes glutamate, and those amino acids that 
can be converted into glutamate, as central carbon sources.  Carbon catabolite 
repression prevents energy expenditure by repressing the expression and activity of 
unnecessary catabolic systems when preferred carbon sources such as glucose are in 
abundance (1, 119, 120).  It has been well documented that the pathways 
interconverting proline and arginine are under repression by the catabolite repressor, 
CcpA, in the presence of glucose as well as their conversion to glutamate via rocA (5, 
37, 41, 128).  Therefore, it was of no surprise to find induction of putA, rocD, rocF, rocA, 
and gudB expression following the exhaustion of glucose in CDMG (Figure 4.1A).  The 
increased expression in JE2 ccpA::tetL compared to wild type JE2 during early-
exponential growth in CDMG confirms this repression is ccpA dependent (Figure 4.1A).  
Furthermore, as predicted, transcription of putA, rocD, rocA, gudB, and rocF was 
detected during exponential growth in CDM (Figure 4.1B), further indicating that 
glutamate, as well as proline and arginine, can be utilized as carbon sources during 
nutrient limitation.    
 Bacterial growth is dependent on the availability of nutrients.  Nutritional 
adaptation allows for the expression of genes involved in the transport and catabolism of 
the nutrients that are available in the environment.  The global regulator, CodY, has 
been well documented to regulate amino acid metabolism in response to nutrient 
starvation by responding to the intracellular concentration of both BCAAs and GTP.  
During the transition from exponential- to stationary-phase growth, decreasing BCAA 
and GTP concentrations lead to derepression of CodY regulated genes (129-131).  
Waters and colleagues have developed a model where a spectrum of CodY activity 
promotes growth in varying BCAA and GTP concentrations.  It was determined that 
under conditions of increasing nutrient depletion, CodY sequentially turns on genes 
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required for transporting nutrients, before turning on genes involved in the de novo 
synthesis of the compound.  Thus, prioritizing nutrient uptake and catabolism, ensures 
that energy and resources are not wasted on synthesizing nutrients that are available in 
the environment (135).       
In studies performed by Waters et al., transcriptional profiling via RNA-seq 
experiments indicated that transcripts of the proline transporters, proP and putP, were 
among the first to be induced following nutrient depletion (135) suggesting that proline 
catabolic genes would also be induced by CodY during nutrient limitation.  Indeed, 
northern blot experiments demonstrated induction of glutamate synthesis genes via 
proline catabolism is CodY-dependent.  In the absence of glucose, and therefore when 
CcpA repression is alleviated, a codY mutant demonstrates decreased induction of putA 
and rocA, when compared to wild type JE2, suggesting CodY activity facilitates 
glutamate synthesis via the activation of proline catabolic genes in the absence of a 
preferred carbon source (Figure 4.1).  A codY mutant also results in a significant growth 
yield defect, similar to that seen in a putA mutant when grown in CDM-E (Figure 4.2), 
further suggesting proline catabolism is regulated by CodY activity.  Collectively, our 
assessments of the induction of glutamate synthesis genes via the catabolism of 
arginine and proline suggest that the presence of glucose represses the transcription of 
these pathways in a CcpA-dependent manner.  In the absence or exhaustion of glucose, 
CodY activity leads to induction of the proline catabolic genes, putA and rocA, facilitating 
the use of proline as a carbon source.   
Regulation of both proline and arginine catabolic pathways leading to the 
synthesis of glutamate have been well characterized in B. subtilis. Several transcriptional 
regulators have been characterized that function to regulate these pathways, including 
PutR, RocR, AhrC, and the aforementioned CcpA and CodY.  While S. aureus does not 
	 104	
encode orthologous PutR or RocR proteins, its genome does encode the arginine 
transcriptional regulator, AhrC.  In fact, it has been reported that three arginine 
transcriptional regulators, ArgR1, ArgR2, and AhrC, are encoded by the S. aureus JE2 
genome (50).  As S. aureus arginine and proline synthesis pathways are interconnected 
and as these ArgR-type regulators have been shown in several gram-positive organisms 
to regulate both arginine anabolism and catabolism (5, 37, 41), we hypothesized one or 
more of the ArgR-type regulators encoded by S. aureus JE2 functioned to regulate 
proline and arginine catabolism.  Growth studies revealed that when grown in CDM-E a 
mutation in argR1 resulted in similar growth defects as seen in putA and codY mutants, 
indicating this mutant is unable to utilize proline for glutamate synthesis (Figure 4.6).    In 
conjunction with these findings, and similar to results seen in the codY mutant, northern 
blot analysis demonstrated that after the exhaustion of glucose in CDMG and during 
exponential growth in CDM, a mutation in argR1 results in loss of expression of putA 
when compared to wild type JE2 (Figure 4.5).  Furthermore, we predicted that a 
mutation in argR2 would have little effect on expression of these pathways, as it is an 
acquired regulator, not native to the chromosome.  Much to our surprise, a mutation in 
argR2, as well as a mutation in ahrC, resulted in moderate growth defects when grown 
in CDM-E (Figure 4.6) and decreased putA expression following glucose exhaustion 
when grown in CDMG, albeit less pronounced than the argR1 mutant (Figure 4.7B and 
4.8B).  These data suggest that all three arginine regulators, in the absence of glucose 
and carbon catabolite repression, have the ability to induce putA expression, thus 
facilitating activation of proline catabolism.  A mutation in argR2 also resulted in delayed 
expression of rocA and increased rocF transcription during exponential growth in CDM, 
while an ahrC mutant had increased rocA expression during exponential growth in CDM 
when compared to wild type (Figure 4.7A and 4.8A), suggesting these regulators also 
have a function in arginine utilization and catabolism.   
	 105	
While these studies indicate that in the absence of glucose, ArgR1, ArgR2, and 
AhrC function in regulating the pathways involved in glutamate synthesis via the 
catabolism of proline and arginine, the mechanisms of regulation remain unclear.  The 
similar lack of growth in CDM-E (Figure 4.2 and 4.6) and loss of expression of putA 
during growth in both CDMG and CDM in the argR1 and codY mutants (Figure 4.3 and 
4.5) suggest both of these regulators are involved in activation of proline catabolism.  As 
nutrients become limiting within the environment, CodY typically induces gene 
expression through loss of repression due to conformational changes induced by 
decreasing BCAA and GTP concentrations.  If loss of CodY repression during nutrient 
depletion functions to induce transcription of putA, we would expect to see increased 
expression of putA in a codY mutant.  However, as we ovserve complete loss of 
transcription of putA in the codY mutant we hypothesize induction of an unknown 
activator, such as ArgR1, by CodY could result in putA transcription.   
We observed similar growth in the argR2 mutant compared to wild type JE2 in 
CDM (Figure 4.9); however, moderate growth defects are seen when grown in CDM-E 
(Figure 4.6), indicating ArgR2 regulates glutamate synthesis under these conditions.  
Indeed, when grown in CDM the argR2 mutant demonstrated increased expression of 
rocF during exponential growth, indicating it represses arginase-mediated arginine 
catabolism (Figure 4.7A).  Delayed expression of rocA in JE2 argr2::ΝΣ when compared 
to wild type JE2 during growth in CDM indicates this mutant is not able to utilize proline 
or arginine during exponential growth (Figure 4.7A); however, growth defects are not 
observed when grown in CDM (Figure 4.9).  These data suggest the argR2 mutant is 
able to utilize other sources of carbon for growth during early exponential growth, while 
arginine and proline may be utilized during post-exponential growth.  Indeed, NMR 
analysis to determine the fate of carbon after amino acid uptake and catabolism in this 
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mutant would provide useful information as to what pathways are being utilized during 
growth in CDM.   
We observed few effects on transcription of glutamate synthesis via proline and 
arginine catabolism pathways during growth in CDM in the ahrC mutant (Figure 4.8A).  
However, we did observe increased hutU transcription during late-exponential growth in 
CDM in the ahrC mutant when compared to wild type JE2 (Figure 4.8A).  Amino acid 
consumption data demonstrated that histidine utilization followed proline and arginine 
exhaustion during growth in CDM (Figure 3.2).  While hutU transcription was not 
observed in wild type during early or late time points in CDM, it was observed in the 
ccpA, codY, and ahrC mutants (Figure 4.1B, 4.3A, and 4.8A).  In B. subtilis, repression 
of hut transcription by CcpA and CodY ensures histidine catabolism is only active when 
absolutely necessary, as histidine synthesis requires an input of 20 high-energy 
phosphate bonds (66).  Increased transcription during early exponential growth in the 
ccpA mutant indicates that even in the absence of a primary carbon source such as 
glucose, CcpA still mediates repression of some genes.  We observed increased 
transcription of hutU in the codY mutant and ahrC mutants during post-exponential 
growth, indicating both of these regulators function to repress histidine catabolism, 
however the mechanism of repression remains unclear.   
 In conclusion, the experiments described above indicate the regulation of 
glutamate synthesis via the catabolism of arginine, proline, and histidine involves several 
transcriptional regulators, including CcpA, CodY, ArgR1, ArgR2, and AhrC, however the 
exact mechanisms of regulation remain unclear.  It has been well documented by our 
group and others that the pathways leading to glutamate synthesis via proline, arginine, 
or histidine degradation are CcpA regulated and not induced in the presence of glucose 
(5, 37, 41), thus, indicating these amino acids are utilized as a carbon source in glucose 
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deplete environments.  These studies also demonstrated that CodY and ArgR1 activity 
facilitate the induction of proline catabolism via putA expression.  While the mechanism 
of putA induction remains unclear, it is possible that as nutrients are depleted from the 
environment, CodY activity results in expression of argR1, which in turn induces 
transcription of putA, however, further investigation is needed to confirm this hypothesis.  
While we are uncertain of the exact functions of ArgR2 and AhrC in the regulation of 
these amino acid catabolic pathways, northern blot and growth analyses suggest that 
they may function to regulate the sequential utilization of proline, arginine, and histidine.  
Indeed, further NMR analysis and transcriptional profiling of these regulator mutants 
should provide useful insight into the mechanisms of the regulation of glutamate 





Concluding Remarks  
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Final observations of amino acid catabolism in S. aureus and Future Directions 
Pathogenic bacteria must readily adapt to changing carbon and nitrogen sources 
to successfully proliferate within their human hosts.  Understanding what metabolic 
pathways are required for growth within specific niches may reveal novel avenues for 
drug development.  S. aureus is capable of establishing an infection in a variety of 
metabolic niches within the human host, most commonly skin and soft tissues.  The work 
presented in this dissertation contributes to an evolving model of S. aureus survival 
within abscesses.  To persist within the human host, S. aureus must not only combat 
host innate defenses, such as NO production, but must also adapt its metabolic 
processes to overcome nutrient limitations at sites of infection (10, 11, 95).  It is 
proposed that the major carbon sources available at the center of staphylococcal 
abscesses are lactate, excreted from bacterial glucose fermentation during NO stress, 
and peptides.  S. aureus is able to utilize lactate via lactate quinone oxidoreductast (Lqo) 
generating pyruvate and subsequently acetate via the ATP-producing PTA/AckA 
pathway; where as peptides are predicted to provide a carbon source for the bacteria to 
fuel gluconeogenesis and biomass production (10).  The goal of this work was to assess 
amino acid catabolism in S. aureus and to determine the importance of particular amino 
acid catabolic pathways during growth without glucose or other preferred carbon 
sources.   
S. aureus encodes pathways to catabolize multiple amino acids, including those 
that generate pyruvate, 2-oxoglutarate, and oxaloacetate.  The data presented here has 
demonstrated that the enzyme GudB, which generates 2-oxoglutarate from glutamate, 
and subsequently those amino acids that lead to glutamate synthesis, is essential for 
growth in media lacking glucose.  We observed that glutamate was primarily synthesized 
through catabolism of proline via PutA and RocA during growth in the presence of amino 
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acids.  These findings contribute to a previously proposed model that predicts that S. 
aureus utilizes both host- and self-derived proteases to liberate free proline or proline-
containing peptides from the fibrin wall when encapsulated within an abscess.  A major 
constituent of the fibrotic wall encapsulating the bacterial cells is collagen and the 
second most abundant amino acid found in collagen is proline (41, 144); thus, 
suggesting a reservoir of proline is present at the site of staphylococcal infection (Figure 
5.6).  Moreover, mutants in the high affinity proline permease, PutP, are less virulent in 
animal models of infection (145, 146).  Collectively, these data and observations suggest 
S. aureus has adapted to the microenvironment of the abscess, utilizing substrates 
provided by the fibrotic wall that encapsulates it for growth and persistence.  Indeed, 
analysis of the proline catabolic putA and rocA mutants and the gudB mutant’s ability to 
survive within a murine abscess model is required to determine the functions and 
importance of these pathways in vivo.  Furthermore, characterization of proteases and 
transporters involved in the liberation and consumption of proline proposed to contribute 
to this model of abscess formation and persistence would provide evidence that S. 
aureus has the ability to utilize proline in nutrient limiting conditions.      
The results of the characterization of amino acid catabolism in S. aureus 
suggests that growth on amino acids is dependent upon ATP generation from 
PTA/AckA, as an ackA mutant was unable to grow in CDM.  In addition, a functional 
respiratory chain was required for growth.  It is not surprising that growth in the presence 
of amino acids would require ATP generation from both substrate level phosphorylation 
and the electron transport chain as amino acid transport requires ATP and is a more 
energy intensive process than carbohydrate transport.  However, it is unclear whether 
this growth phenotype is due to loss of ATP generation or disruption of intracellular 
acetyl-phosphate pools, as acetyl-phosphate is a key coeffector molecule in the cell.  
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Growth analysis of a serine dehydratase and alanine dehydrogenase double mutant, 
abolishing the cells ability to utilize glucogenic amino acids for pyruvate and subsequent 
acetate generation, would provide further information on the contribution of ATP 
generation via PTA/AckA to growth on amino acids.   
Arginine is proposed to be limiting within abscesses due to utilization by host 
innate immune responses and bacterial scavenging, however, its function in S. aureus 
pathogenesis remains unclear.  It is hypothesized that ADI activity could be important for 
pathogenesis, as arginine catabolism via the ADI pathway provides pH homeostasis and 
energy generation via ammonia and ATP production to a variety of bacteria, including 
staphylococcal species, contributing to the overall fitness of these organisms during 
growth in specific niches (16, 55, 57).  It is unclear how arginine is utilized in CDM, as 
the arcA1/arcA2/rocF triple mutant showed only slight growth yield defects.  It is possible 
that arginine catabolism via ADI could be contributing to ATP production or pH 
homeostasis during growth in the absence of preferred carbon sources as citrulline 
formation was detected in NMR analysis of arginine utilization (Figure 3.7).  Citrulline is 
an intermediate of all three arginine catabolic pathways (argininase, ADI, and NOS 
pathways), which can synthesize ATP and ammonia via ArcC.  While it is assumed that 
transposon mutations in arcA1 and arcA2 facilitate polar mutations, disrupting 
transcription of all genes involved in the arc operon, it is possible that the ArcC enzyme 
is functional in these mutants, allowing for ATP generation.  Growth analysis and murine 
abscess models of infection utilizing an arcC1/arcC2 mutant could provide more 
knowledge of the contribution of ADI during growth on alternative carbon sources.  
Furthermore, growth analysis of a nos mutant could also provide information as to what 
pathways are utilizing arginine during growth in these conditions. 
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Final observations on regulation of amino acid catabolism  
As previously discussed, S. aureus has shown to be a proline and arginine 
auxotroph (39), with growth in CDMG lacking either proline or arginine (CDMG-P, 
CDMG-R)  being dependent upon alleviation of CcpA repression (5, 37, 41).  Our 
studies, and others, have demonstrated that the multiple pathways fueling glutamate 
synthesis (via proline, arginine, and histidine), and subsequent conversion to 2-
oxoglutarate via GudB, are all under the repression of CcpA and only active during 
growth on non-preferred carbon sources (5, 37, 41). It was predicated that growth 
defects in CDM lacking arginine or proline would be observed in JE2 as CcpA repression 
is alleviated.  Although moderate defects were observed, JE2 could grow in the absence 
of proline in a RocF-dependent manner, suggesting utilization of arginine for both proline 
and glutamate synthesis (Figure 5.1A).  However, we only observed growth in CDM-R 
when ccpA was inactivated (Figure 5.1B).  Complementing these findings, NMR analysis 
demonstrated that proline utilization does not facilitate arginine synthesis during growth 
in CDM.  It is unclear how CcpA is functioning to repress arginine biosynthesis in the 
absence of arginine.  However, the detection of argG transcript, which encodes the urea 
cycle enzyme argininosuccinate lyase and is required for arginine biosynthesis, during 
post-exponential growth in CDM in both JE2 and the ccpA mutant, demonstrates 
arginine biosynthesis is induced after the exhaustion of arginine from CDM during post-
exponential growth (Figure 5.2A), thus, suggesting another regulator functions to induce 
arginine biosynthesis in the absence of arginine. The arginine transcriptional regulator, 
AhrC, has been well characterized in B. subtilis, functioning to repress arginine 
biosynthesis in the presence of arginine, while simultaneously activating arginine 
catabolism via the arginase pathway (143).  While we were surprised to determine AhrC 
had little effect on the activation of arginine catabolism  
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Figure 5.1.  Growth of S. aureus JE2 and JE2 ccpA::tetL in CDM and CDM 
lacking arginine (CDM-R). Aerobic growth of JE2 ccpA::tetL in CDM (A) and 
CDM-R (B) in comparison to wild type JE2.  Data represents means ± SEM of 




via the arginase pathway during growth in CDM, our data does suggest AhrC is 
functioning to repress transcription of arginine biosynthesis under these conditions.  
Northern blot analysis of the ahrC mutant during early-exponential growth in CDM 
demonstrated increased argG transcription when compared to wild type JE2 (Figure 
5.2B).  Arginine is still available in the media during early-exponential growth in CDM 
(Figure 3.2), suggesting AhrC is repressing arginine biosynthesis in an arginine-
dependent manner.  After further analysis of argG transcription, we were surprised to 
determine that while ArgR1 had no effect on transcription, ArgR2 is also functioning to 
repress argG during growth in CDM (Figure 5.2C and 5.2D).  As ArgR2 was acquired 
with the addition of the ACME island to the S. aureus USA300 JE2 genome (50), it 
would be interesting to compare regulation of argG to strains without the ACME element 
or in a JE2 ΔACME mutant. 
In most bacteria, arginine is typically synthesized via glutamate catabolism and 
the argJBCDFGH pathway.  However Nuxoll et al. demonstrated that this pathway in S. 
aureus is inactive and that proline serves as a substrate for arginine biosynthesis via 
PutA, RocD and the urea cycle, including ArgG, in the absence of CcpA repression (41).  
We hypothesized that AhrC could be functioning to repress the argJBCD operon in the 
presence of arginine; however, we observed no expression of argJ in the ahrC mutant 
(Figure 5.3).  Furthermore, we were unable to detect argJ transcript in ArgR1 or ArgR2 
during growth in CDM (Figure 5.3).  Interestingly, further characterization of the arginine 
transcriptional regulators revealed ArgR1, and to a lesser extent ArgR2, function to 
activate putA expression after exhaustion of glucose in CDMG (Figure 4.5B and 4.7B).  
AhrC, however, repressed putA transcription in an arginine-dependent manner (Figure 
4.8), further implicating its function in repression of arginine biosynthesis in the presence 
of arginine.   Collectively, these results indicate these arginine transcriptional regulators  
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Figure 5.2.  Transcriptional analysis of argG in S. aureus.  Northern 
analysis was performed with RNA isolated from exponential (early) and 
post-exponential (late) phases of growth in CDM in wild type JE2, JE2 
ccpA::tetL (A), JE2 ΔahrC (B), JE2 argR1::ΝΣ (C), and JE2 argR2::ΝΣ (D).  
Equal loading of RNA was ensured via staining of the RNA gel with ethidium 




Figure 5.3.  Transcriptional analysis of argJ in S. aureus JE2 and the 
various regulator mutants.  Northern analysis was performed with RNA 
isolated from exponential (early) and post-exponential (late) phases of 
growth in CDM  from JE2, JE2 argR1::ΝΣ, JE2 argR2::ΝΣ, JE2 ΔahrC, JE2 
ccpA::tetL, and JE2 codY::ΝΣ.  Genomic DNA from JE2 was used as a 
positive control to ensure the argJ probe was functional.  Equal loading of 
RNA was ensured via staining of the RNA gel with ethidium bromide and 
visualization of the 16s and 23s rRNA (data not shown).   
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have evolved in the regulation of arginine biosynthesis from glutamate catabolic genes 
to proline catabolic genes.  Perhaps, S. aureus has adapted both its metabolic pathway 
preferences and its regulatory mechanisms to utilize proline instead of glutamate, as 
proline is potentially in abundance during infection.    
The global regulator, CodY, directly or indirectly controls the expression of over 
200 genes in S. aureus, including those involved in metabolism and virulence, allowing 
the organism to efficiently utilize available nutrient sources and avoiding wasteful energy 
expenditure by synthesizing unnecessary macromolecules.  CodY regulation of proline 
metabolism was recently implicated in studies performed by Waters et al. as proP and 
putP genes encoding proline transporters were among the first to be expressed following 
nutrient depletion and derepression of CodY (135).  Furthermore, the ability to transport 
proline has been linked to virulence, as mutants in putP are less virulent in animal 
models of infection (145, 146).  These data suggest that proline catabolic pathways are 
also regulated via CodY derepression and nutrient limitation.  Indeed, our studies 
implicated CodY involvement in putA transcription as a codY mutant had decreased 
induction of expression after alleviation of repression via CcpA (Figure 4.3).  CodY 
activation of genes typically induces gene transcription via loss of repression; therefore, 
it is hypothesized that CodY activation of putA expression in the absence of CcpA 
repression occurs through derepression of an auxiliary transcriptional regulator, perhaps 
one that senses the availability of proline.  
Amino acid consumption data indicated that histidine was consumed when 
glucose is limiting.  Indeed, genetic and NMR analyses demonstrated that histidine can 
be utilized as a substrate for glutamate synthesis via the hut genes; thus, it can also 
serve as a carbon source in the absence of glucose.   As both CcpA and CodY repress 
histidine catabolism in B. subtilis, we predicted they would also be involved in hut 
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repression in S. aureus.  Much to our surprise, hut induction was not detected in 
northern blot analyses of early- and late-exponential time points during growth of JE2 in 
CDM (Figure 4.1), even though NMR studies determined that the presence of histidine 
facilitated glutamate synthesis during late-exponential growth (Figure 3.7).  However, we 
did detect hut transcription in CcpA and CodY mutants, indicating that histidine 
catabolism is only induced during carbon and nutritional limitation (Figure 4.1B and 
4.3A).  Histidine is one of the most expensive amino acids for the cell to synthesize, 
requiring an input of 20 high-energy phosphate bonds (66), suggesting it would only be 
catabolized during extreme carbon and nutrient limitations.  To further suggest histidine 
utilization is only induced during times of starvation, AhrC also repressed hut 
transcription in an arginine-dependent manner (Figure 4.8).  Figures 5.4 and 5.5 
summarize our proposed model of the regulation of the proline, glutamate, and arginine 
metabolic pathways in the presence and absence of preferred carbon.  Figure 5.6 
depicts the proposed model of S. aureus survival within an abscess. 
Future Directions 
The work presented in this dissertation provides evidence that proline can be 
utilized as a carbon source for bacterial growth in carbon limiting environments via its 
conversion to glutamate, which is further utilized to drive TCA cycle activity and 
gluconeogenesis, thus, providing the cell with carbon to fuel biomass production.  CcpA 
repression in the presence of glucose further suggests the importance of the utilization 
of glutamate and those amino acids that synthesize glutamate as carbon sources, as 
these pathways are only induced during carbon limitation.  Further characterization of 
the mechanisms of regulation involved in the interconnected pathways of glutamate, 
proline, arginine, and histidine metabolism indicated that CodY and the arginine 
transcriptional regulators AhrC, ArgR1, and ArgR2 are involved in controlling the 
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expression of these pathways.  It seems likely that AhrC and ArgR2 function to repress 
arginine biosynthesis in the presence of arginine and that CodY activity regulates proline 
catabolism during nutrient limitation. Additionally, ArgR1 appears to activate proline 
catabolism in a CcpA-dependent manner, however, further experimentation is required 
to confirm this hypothesis.  Indeed, NMR analysis of the fates of proline, arginine, 
histidine, and histidine in all five regulator mutants (CcpA, CodY, AhrC, ArgR1, and 
ArgR2) when grown in CDM would provide useful information as to what catabolic 
pathways these regulators function to activate or repress.  Moreover, amino acid 
consumption analyses in these mutants could indicate if these regulators are involved in 
the regulation of transport of these amino acids.  In conclusion, the findings of this 
dissertation further characterize the metabolic and regulatory nodes involved in carbon 





Figure 5.4 Regulation of glutamate synthesis in the presence of a 
preferred carbon source.  In the presence of a preferred carbon source 
such as glucose, CcpA functions to repress most genes involved in the 





Figure 5.5 Regulation of glutamate synthesis in the absence of a 
preferred carbon source.  In the absence of a preferred carbon source 
such as glucose, CcpA alleviation (not including hut repression) allows for 
expression of glutamate synthesis genes via amino acid catabolism.  Hut 
transcription is repressed in the absence of glucose by CcpA, CodY, and 
AhrC activity, in CDM this repression is hypothesized to be functioning due 
to the presence of proline and arginine.  Transcription of putA is positively 
regulated by ArgR1 and CodY.  Northern blot data suggests CodY activation 
is through derepression of an unknown activator, perhaps sensing proline 
availability.  Transcription of ArgG is repressed by CcpA, ArgR2, and AhrC 
in the absence of glucose.  In CDM, this repression is hypothesized to be 




Figure 5.6 Proposed model of S. aureus abscess survival.  It is 
proposed the staphylococcal abscess is carbon limited due to both 
immune and bacterial cells utilizing glucose at the onset of infection.  
Host factors such as iNOS and arginase (1A) utilize arginine for nitric 
oxide production (iNOS) and collagen production (arginase).  Bacterial 
cells utilize arginine via ADI for ATP and ammonia production.  Due to 
the depletion of glucose, it is hypothesized that CcpA repression is 
alleviated, allowing for utilization of amino acids such as proline as 
carbon sources.  The fibrin wall is cleaved by bacterial secreted 
proteases such as ScpA, SspB, and aureolysin (2), as well as host 
proteases such as MMP-9 (2), to liberate free proline or proline 
containing peptides (3).  The bacterial cells are then able to utilize these 
free peptides and amino acids through specific transporters as carbon 











3.	 Richardson	 AR,	 Libby	 SJ,	 Fang	 FC.	 2008.	 A	 nitric	 oxide-inducible	 lactate	
dehydrogenase	 enables	 Staphylococcus	 aureus	 to	 resist	 innate	 immunity.	 Science	
319:1672-1676.	
4.	 Hammer	ND,	Reniere	ML,	Cassat	JE,	Zhang	Y,	Hirsch	AO,	Indriati	Hood	M,	Skaar	





6.	 Hiron	 A,	 Borezee-Durant	 E,	 Piard	 JC,	 Juillard	 V.	 2007.	 Only	 one	 of	 four	
oligopeptide	 transport	 systems	 mediates	 nitrogen	 nutrition	 in	 Staphylococcus	
aureus.	J	Bacteriol	189:5119-5129.	












10.	 Spahich	 NA,	 Vitko	 NP,	 Thurlow	 LR,	 Temple	 B,	 Richardson	 AR.	 2016.	
Staphylococcus	 aureus	 lactate-	 and	malate-quinone	 oxidoreductases	 contribute	 to	
nitric	oxide	resistance	and	virulence.	Mol	Microbiol	doi:10.1111/mmi.13347.	
11.	 Fuller	 JR,	Vitko	NP,	Perkowski	EF,	 Scott	E,	Khatri	D,	 Spontak	 JS,	Thurlow	LR,	
Richardson	 AR.	 2011.	 Identification	 of	 a	 lactate-quinone	 oxidoreductase	 in	












16.	 Liu	 S,	 Pritchard	 GG,	 Hardman	 MJ,	 Pilone	 GJ.	 1995.	 Occurrence	 of	 arginine	
deiminase	 pathway	 enzymes	 in	 arginine	 catabolism	 by	 wine	 lactic	 Acid	 bacteria.	
Appl	Environ	Microbiol	61:310-316.	
17.	 Nisman	 B,	 Raynaud	 M,	 Cohen	 GN.	 1948.	 Extension	 of	 the	 Stickland	 reaction	 to	
several	bacterial	species.	Arch	Biochem	16:473.	
18.	 Stickland	 LH.	 1934.	 Studies	 in	 the	 metabolism	 of	 the	 strict	 anaerobes	 (genus	
Clostridium):	 The	 chemical	 reactions	 by	 which	 Cl.	 sporogenes	 obtains	 its	 energy.	
Biochem	J	28:1746-1759.	
19.	 Stickland	 LH.	 1935.	 Studies	 in	 the	 metabolism	 of	 the	 strict	 anaerobes	 (Genus	
Clostridium):	The	reduction	of	proline	by	Cl.	sporogenes.	Biochem	J	29:288-290.	









24.	 Picossi	 S,	 Belitsky	 BR,	 Sonenshein	 AL.	 2007.	 Molecular	 mechanism	 of	 the	
regulation	of	Bacillus	subtilis	gltAB	expression	by	GltC.	J	Mol	Biol	365:1298-1313.	
25.	 Gunka	 K,	 Commichau	 FM.	 2012.	 Control	 of	 glutamate	 homeostasis	 in	 Bacillus	





27.	 Commichau	 FM,	 Forchhammer	 K,	 Stulke	 J.	 2006.	 Regulatory	 links	 between	
carbon	and	nitrogen	metabolism.	Curr	Opin	Microbiol	9:167-172.	








subtilis	 arginine	 repressor/activator,	 AhrC:	 novel	 positioning	 and	 DNA-mediated	
assembly	of	a	transcriptional	activator	at	catabolic	sites.	Mol	Microbiol	26:37-48.	
32.	 Gardan	R,	 Rapoport	 G,	Debarbouille	M.	1995.	Expression	of	 the	rocDEF	operon	
involved	in	arginine	catabolism	in	Bacillus	subtilis.	J	Mol	Biol	249:843-856.	
33.	 Commichau	 FM,	Wacker	 I,	 Schleider	 J,	 Blencke	HM,	 Reif	 I,	 Tripal	 P,	 Stulke	 J.	
2007.	Characterization	of	Bacillus	subtilis	mutants	with	carbon	source-independent	
glutamate	biosynthesis.	J	Mol	Microbiol	Biotechnol	12:106-113.	
34.	 Debarbouille	 M,	 Martin-Verstraete	 I,	 Kunst	 F,	 Rapoport	 G.	 1991.	 The	Bacillus	
subtilis	 sigL	gene	encodes	an	equivalent	of	 sigma	54	 from	gram-negative	bacteria.	
Proc	Natl	Acad	Sci	U	S	A	88:9092-9096.	
35.	 Choi	SK,	Saier	MH,	Jr.	2005.	Regulation	of	sigL	expression	by	the	catabolite	control	
protein	 CcpA	 involves	 a	 roadblock	 mechanism	 in	 Bacillus	 subtilis:	 potential	
connection	between	carbon	and	nitrogen	metabolism.	J	Bacteriol	187:6856-6861.	
	 125	
36.	 Abraham	L.	 Sonenshein	 JAH,	and	Richard	M.	Losick.	2002.	Bacillus	subtilis	and	
Its	Closest	Relatives:	from	Genes	to	Cells.	ASM	Press,	Washington,	D.C.	
37.	 Townsend	 DE,	 Kaenjak	 A,	 Jayaswal	 RK,	 Wilkinson	 BJ.	 1996.	 Proline	 is	




39.	 Gladstone	 GP.	 1937.	 The	 nutrition	 of	 Staphylococcus	 aureus;	 nitrogen	
requirements.	Br	J	Exp	Pathol	18:322-333.	
40.	 Kuroda	M,	Ohta	T,	Uchiyama	I,	Baba	T,	Yuzawa	H,	Kobayashi	I,	Cui	L,	Oguchi	A,	
Aoki	 K,	 Nagai	 Y,	 Lian	 J,	 Ito	 T,	 Kanamori	 M,	 Matsumaru	 H,	 Maruyama	 A,	
Murakami	H,	Hosoyama	A,	Mizutani-Ui	 Y,	 Takahashi	NK,	 Sawano	T,	 Inoue	R,	
Kaito	 C,	 Sekimizu	 K,	 Hirakawa	H,	 Kuhara	 S,	 Goto	 S,	 Yabuzaki	 J,	 Kanehisa	M,	
Yamashita	A,	Oshima	K,	Furuya	K,	Yoshino	C,	Shiba	T,	Hattori	M,	Ogasawara	N,	
Hayashi	 H,	 Hiramatsu	 K.	 2001.	Whole	genome	sequencing	of	meticillin-resistant	
Staphylococcus	aureus.	Lancet	357:1225-1240.	
41.	 Nuxoll	 A,	Halouska	 S,	 Sadykov	M,	Hanke	M,	 Bayles	KW,	Kielian	T,	 Powers	R,	
Fey	 PD.	 2012.	 CcpA	 regulates	 Arginine	 Biosynthesis	 in	 Staphylococcus	 aureus	
through	repression	of	proline	catabolism.	PLoS	Pathogens	8:e1003033.	
42.	 Schreier	 HJ,	 Brown	 SW,	 Hirschi	 KD,	 Nomellini	 JF,	 Sonenshein	 AL.	 1989.	
Regulation	of	Bacillus	subtilis	glutamine	synthetase	gene	expression	by	the	product	
of	the	glnR	gene.	J	Mol	Biol	210:51-63.	
43.	 Moses	 S,	 Sinner	 T,	 Zaprasis	 A,	 Stoveken	 N,	 Hoffmann	 T,	 Belitsky	 BR,	
Sonenshein	AL,	Bremer	E.	2012.	Proline	Utilization	by	Bacillus	subtilis:	Uptake	and	
Catabolism.	J	Bacteriol	194:745-758.	
44.	 Zhou	 Y,	 Zhu	 W,	 Bellur	 PS,	 Rewinkel	 D,	 Becker	 DF.	 2008.	 Direct	 linking	 of	





47.	 Emmett	 M,	 Kloos	 WE.	 1975.	 Amino	 acid	 requirements	 of	 staphylococci	 isolated	
from	human	skin.	Can	J	Microbiol	21:729-733.	
48.	 Gardan	R,	Rapoport	G,	Debarbouille	M.	1997.	Role	of	the	transcriptional	activator	





50.	 Diep	 BA,	 Gill	 SR,	 Chang	 RF,	 Phan	 TH,	 Chen	 JH,	 Davidson	 MG,	 Lin	 F,	 Lin	 J,	
Carleton	 HA,	 Mongodin	 EF,	 Sensabaugh	 GF,	 Perdreau-Remington	 F.	 2006.	
Complete	genome	sequence	of	USA300,	 an	epidemic	 clone	of	 community-acquired	
meticillin-resistant	Staphylococcus	aureus.	Lancet	367:731-739.	
51.	 Thurlow	LR,	 Joshi	GS,	Clark	 JR,	 Spontak	 JS,	Neely	CJ,	Maile	R,	Richardson	AR.	
2013.	Functional	modularity	of	the	arginine	catabolic	mobile	element	contributes	to	







54.	 Larsen	R,	 Kok	 J,	 Kuipers	OP.	2005.	 Interaction	between	ArgR	and	AhrC	controls	
regulation	 of	 arginine	 metabolism	 in	 Lactococcus	 lactis.	 J	 Biol	 Chem	 280:19319-
19330.	
55.	 Fulde	 M,	Willenborg	 J,	 de	 Greeff	 A,	 Benga	 L,	 Smith	 HE,	 Valentin-Weigand	 P,	
Goethe	 R.	2011.	ArgR	 is	an	essential	 local	 transcriptional	 regulator	of	 the	arcABC	
operon	 in	 Streptococcus	 suis	 and	 is	 crucial	 for	 biological	 fitness	 in	 an	 acidic	
environment.	Microbiology	157:572-582.	
56.	 Liu	 Y,	 Burne	 RA.	 2009.	 Multiple	 two-component	 systems	 modulate	 alkali	
generation	 in	 Streptococcus	 gordonii	 in	 response	 to	 environmental	 stresses.	 J	
Bacteriol	191:7353-7362.	
57.	 Lindgren	 JK,	 Thomas	 VC,	 Olson	 ME,	 Chaudhari	 SS,	 Nuxoll	 AS,	 Schaeffer	 CR,	
Lindgren	KE,	 Jones	J,	Zimmerman	MC,	Dunman	PM,	Bayles	KW,	Fey	PD.	2014.	





inhibitors	 and	 nitric	 oxide	 donors	 modulate	 the	 biosynthesis	 of	 thaxtomin	 A,	 a	
nitrated	phytotoxin	produced	by	Streptomyces	spp.	Nitric	Oxide	12:46-53.	
60.	 Shatalin	 K,	 Gusarov	 I,	 Avetissova	 E,	 Shatalina	 Y,	 McQuade	 LE,	 Lippard	 SJ,	





2014.	 Contribution	 of	 the	 nos-pdt	 operon	 to	 virulence	 phenotypes	 in	 methicillin-
sensitive	Staphylococcus	aureus.	PLoS	One	9:e108868.	




65.	 Kaminskas	 E,	 Kimhi	 Y,	 Magasanik	 B.	 1970.	 Urocanase	 and	 N-formimino-L-
glutamate	 formiminohydrolase	 of	 Bacillus	 subtilis,	 two	 enzymes	 of	 the	 histidine	
degradation	pathway.	J	Biol	Chem	245:3536-3544.	
66.	 Akashi	H,	Gojobori	T.	2002.	Metabolic	efficiency	and	amino	acid	composition	in	the	
proteomes	 of	 Escherichia	 coli	 and	 Bacillus	 subtilis.	 Proc	 Natl	 Acad	 Sci	 U	 S	 A	
99:3695-3700.	






69.	 Wray	LV,	 Jr.,	 Fisher	 SH.	1994.	Analysis	of	Bacillus	subtilis	hut	operon	expression	
indicates	 that	 histidine-dependent	 induction	 is	 mediated	 primarily	 by	
transcriptional	antitermination	and	that	amino	acid	repression	is	mediated	by	two	








72.	 Kim	 JH,	 Chambliss	 GH.	 1997.	 Contacts	 between	 Bacillus	 subtilis	 catabolite	
regulatory	protein	CcpA	and	amyO	target	site.	Nucleic	Acids	Res	25:3490-3496.	
73.	 Sauer	 U,	 Eikmanns	 BJ.	 2005.	 The	 PEP-pyruvate-oxaloacetate	 node	 as	 the	 switch	
point	for	carbon	flux	distribution	in	bacteria.	FEMS	Microbiol	Rev	29:765-794.	
74.	 Fisher	 SH,	 Magasanik	 B.	 1984.	 Synthesis	 of	 oxaloacetate	 in	 Bacillus	 subtilis	
mutants	 lacking	the	2-ketoglutarate	dehydrogenase	enzymatic	complex.	 J	Bacteriol	
158:55-62.	
75.	 Diesterhaft	 MD,	 Freese	 E.	 1973.	 Role	 of	 pyruvate	 carboxylase,	









Jawa	 RS,	 Zimmerman	MC,	 Bayles	 KW.	 2014.	A	 central	 role	 for	 carbon-overflow	
pathways	in	the	modulation	of	bacterial	cell	death.	PLoS	Pathog	10:e1004205.	
79.	 Freese	 E,	 Park	 SW,	 Cashel	 M.	 1964.	 The	 Developmental	 Significance	 of	 Alanine	
Dehydrogenase	in	Bacillus	Subtilis.	Proc	Natl	Acad	Sci	U	S	A	51:1164-1172.	
80.	 Siranosian	 KJ,	 Ireton	 K,	 Grossman	 AD.	 1993.	 Alanine	 dehydrogenase	 (ald)	 is	
required	for	normal	sporulation	in	Bacillus	subtilis.	J	Bacteriol	175:6789-6796.	
81.	 Fey	PD,	Endres	JL,	Yajjala	VK,	Widhelm	TJ,	Boissy	RJ,	Bose	JL,	Bayles	KW.	2013.	








84.	 Hussain	M,	Hastings	 JG,	White	 PJ.	1991.	A	chemically	defined	medium	 for	slime	
production	by	coagulase-negative	staphylococci.	J	Med	Microbiol	34:143-147.	
85.	 Yanisch-Perron	C,	Vieira	J,	Messing	J.	1985.	Improved	M13	phage	cloning	vectors	
and	host	 strains:	 nucleotide	 sequences	 of	 the	M13mp18	 and	pUC19	 vectors.	 Gene	
33:103-119.	
86.	 Projan	 SJ,	 Archer	 GL.	 1989.	Mobilization	 of	 the	 relaxable	 Staphylococcus	 aureus	





origin	 of	 conjugative	 transfer	 (oriT)	 and	 a	 gene	 (nes)	 encoding	 a	 single-stranded	
endonuclease	on	the	staphylococcal	plasmid	pGO1.	J	Bacteriol	178:4975-4983.	
	 128	
89.	 Bose	 JL,	 Fey	 PD,	 Bayles	 KW.	 2013.	 Genetic	 tools	 to	 enhance	 the	 study	 of	 gene	
function	and	regulation	in	Staphylococcus	aureus.	Appl	Environ	Microbiol	79:2218-
2224.	
90.	 Kreiswirth	 BN,	 Lofdahl	 S,	 Betley	 MJ,	 O'Reilly	 M,	 Schlievert	 PM,	 Bergdoll	 MS,	
Novick	 RP.	 1983.	 The	 toxic	 shock	 syndrome	 exotoxin	 structural	 gene	 is	 not	
detectably	transmitted	by	a	prophage.	Nature	305:709-712.	
91.	 Nuxoll	AS,	Halouska	SM,	Sadykov	MR,	Hanke	ML,	Bayles	KW,	Kielian	T,	Powers	
R,	 Fey	 PD.	 2012.	 CcpA	 regulates	 arginine	 biosynthesis	 in	 Staphylococcus	 aureus	
through	repression	of	proline	catabolism.	PLoS	Pathog	8:e1003033.	
92.	 Xie	QW,	Cho	HJ,	Calaycay	J,	Mumford	RA,	Swiderek	KM,	Lee	TD,	Ding	A,	Troso	T,	
Nathan	 C.	 1992.	 Cloning	 and	 characterization	 of	 inducible	 nitric	 oxide	 synthase	
from	mouse	macrophages.	Science	256:225-228.	
93.	 Fang	 FC.	 2004.	 Antimicrobial	 reactive	 oxygen	 and	 nitrogen	 species:	 concepts	 and	
controversies.	Nat	Rev	Microbiol	2:820-832.	
94.	 Crooke	 AK,	 Fuller	 JR,	 Obrist	 MW,	 Tomkovich	 SE,	 Vitko	 NP,	 Richardson	 AR.	





Lian	 T,	 Jackson	 L,	 Gong	 H,	 Swayze	 R,	 Amandoron	 E,	 Hormozdiari	 F,	 Dao	 P,	
Sahinalp	 C,	 Santos-Filho	O,	 Axerio-Cilies	 P,	 Byler	 K,	McMaster	WR,	 Brunham	
RC,	 Finlay	 BB,	 Reiner	 NE.	 2011.	 Mapping	 the	 protein	 interaction	 network	 in	
methicillin-resistant	Staphylococcus	aureus.	J	Proteome	Res	10:1139-1150.	
97.	 Kumar	 NS,	 Dullaghan	 EM,	 Finlay	 BB,	 Gong	 H,	 Reiner	 NE,	 Jon	 Paul	 Selvam	 J,	
Thorson	LM,	Campbell	S,	Vitko	N,	Richardson	AR,	Zoraghi	R,	Young	RN.	2014.	
Discovery	and	optimization	of	a	new	class	of	pyruvate	kinase	inhibitors	as	potential	
therapeutics	 for	 the	 treatment	 of	 methicillin-resistant	 Staphylococcus	 aureus	
infections.	Bioorg	Med	Chem	22:1708-1725.	
98.	 Zoraghi	R,	See	RH,	Axerio-Cilies	P,	Kumar	NS,	Gong	H,	Moreau	A,	Hsing	M,	Kaur	
S,	 Swayze	RD,	Worrall	 L,	Amandoron	E,	 Lian	T,	 Jackson	L,	 Jiang	 J,	Thorson	L,	
Labriere	 C,	 Foster	 L,	 Brunham	 RC,	 McMaster	 WR,	 Finlay	 BB,	 Strynadka	 NC,	
Cherkasov	 A,	 Young	 RN,	 Reiner	 NE.	 2011.	 Identification	 of	 pyruvate	 kinase	 in	
methicillin-resistant	 Staphylococcus	 aureus	 as	 a	 novel	 antimicrobial	 drug	 target.	
Antimicrob	Agents	Chemother	55:2042-2053.	
99.	 Zoraghi	R,	See	RH,	Gong	H,	Lian	T,	Swayze	R,	Finlay	BB,	Brunham	RC,	McMaster	
WR,	 Reiner	 NE.	 2010.	 Functional	 analysis,	 overexpression,	 and	 kinetic	
characterization	 of	 pyruvate	 kinase	 from	 methicillin-resistant	 Staphylococcus	
aureus.	Biochemistry	49:7733-7747.	
100.	 Cheng	 AG,	 Kim	 HK,	 Burts	 ML,	 Krausz	 T,	 Schneewind	 O,	 Missiakas	 DM.	 2009.	
Genetic	requirements	for	Staphylococcus	aureus	abscess	formation	and	persistence	
in	host	tissues.	FASEB	J	23:3393-3404.	
101.	 Thammavongsa	 V,	 Kim	 HK,	 Missiakas	 D,	 Schneewind	 O.	 2015.	 Staphylococcal	
manipulation	of	host	immune	responses.	Nat	Rev	Microbiol	13:529-543.	
102.	 Cheng	 AG,	 DeDent	 AC,	 Schneewind	 O,	Missiakas	 D.	2011.	A	 play	 in	 four	














107.	 Grundling	 A,	 Schneewind	 O.	 2007.	 Genes	 required	 for	 glycolipid	 synthesis	 and	
lipoteichoic	acid	anchoring	in	Staphylococcus	aureus.	J	Bacteriol	189:2521-2530.	
108.	 Clements	 MO,	 Watson	 SP,	 Poole	 RK,	 Foster	 SJ.	 1999.	 CtaA	 of	 Staphylococcus	
aureus	is	required	for	starvation	survival,	recovery,	and	cytochrome	biosynthesis.	J	
Bacteriol	181:501-507.	
109.	 Voggu	 L,	 Schlag	 S,	 Biswas	 R,	 Rosenstein	 R,	 Rausch	 C,	 Gotz	 F.	 2006.	
Microevolution	 of	 cytochrome	 bd	 oxidase	 in	 Staphylococci	 and	 its	 implication	 in	
resistance	 to	 respiratory	 toxins	 released	 by	 Pseudomonas.	 J	 Bacteriol	 188:8079-
8086.	
110.	 Gotz	 F,	Mayer	 S.	2013.	Both	terminal	oxidases	contribute	to	 fitness	and	virulence	
during	organ-specific	Staphylococcus	aureus	colonization.	MBio	4:e00976-00913.	










115.	 Lithgow	 JK,	 Hayhurst	 EJ,	 Cohen	 G,	 Aharonowitz	 Y,	 Foster	 SJ.	 2004.	 Role	 of	 a	
cysteine	synthase	in	Staphylococcus	aureus.	J	Bacteriol	186:1579-1590.	







119.	 Magasanik	 B.	 1961.	 Catabolite	 repression.	 Cold	 Spring	 Harb	 Symp	 Quant	 Biol	
26:249-256.	
120.	 Gorke	 B,	 Stulke	 J.	 2008.	 Carbon	 catabolite	 repression	 in	 bacteria:	many	ways	 to	
make	the	most	out	of	nutrients.	Nat	Rev	Microbiol	6:613-624.	
121.	 Warner	 JB,	 Lolkema	 JS.	 2003.	 CcpA-dependent	 carbon	 catabolite	 repression	 in	
bacteria.	Microbiol	Mol	Biol	Rev	67:475-490.	
122.	 Hanson	 KG,	 Steinhauer	 K,	 Reizer	 J,	 Hillen	 W,	 Stulke	 J.	 2002.	 HPr	
kinase/phosphatase	 of	 Bacillus	 subtilis:	 expression	 of	 the	 gene	 and	 effects	 of	
	 130	






dependent	 HPr/CcpA	 interaction	 links	 glycolytic	 activity	 to	 carbon	 catabolite	
repression	in	gram-positive	bacteria.	Mol	Microbiol	15:1049-1053.	
125.	 Galinier	A,	Deutscher	J,	Martin-Verstraete	I.	1999.	Phosphorylation	of	either	crh	





127.	 Deutscher	 J,	 Francke	 C,	 Postma	 PW.	 2006.	 How	 phosphotransferase	 system-
related	 protein	 phosphorylation	 regulates	 carbohydrate	 metabolism	 in	 bacteria.	
Microbiol	Mol	Biol	Rev	70:939-1031.	
128.	 Seidl	K,	Muller	S,	Francois	P,	Kriebitzsch	C,	Schrenzel	J,	Engelmann	S,	Bischoff	




130.	 Shivers	 RP,	 Sonenshein	 AL.	 2004.	 Activation	 of	 the	 Bacillus	 subtilis	 global	
regulator	 CodY	 by	 direct	 interaction	 with	 branched-chain	 amino	 acids.	 Mol	
Microbiol	53:599-611.	
131.	 Ratnayake-Lecamwasam	M,	Serror	P,	Wong	KW,	Sonenshein	AL.	2001.	Bacillus	







134.	 Majerczyk	 CD,	 Dunman	 PM,	 Luong	 TT,	 Lee	 CY,	 Sadykov	 MR,	 Somerville	 GA,	
Bodi	 K,	 Sonenshein	 AL.	 2010.	Direct	 targets	 of	CodY	 in	 Staphylococcus	 aureus.	 J	
Bacteriol	192:2861-2877.	
135.	 Waters	NR,	Samuels	DJ,	Behera	RK,	Livny	J,	Rhee	KY,	Sadykov	MR,	Brinsmade	
SR.	 2016.	 A	 spectrum	 of	 CodY	 activities	 drives	 metabolic	 reorganization	 and	
virulence	gene	expression	in	Staphylococcus	aureus.	Mol	Microbiol	101:495-514.	




138.	 Mengin-Lecreulx	 D,	 Falla	 T,	 Blanot	 D,	 van	 Heijenoort	 J,	 Adams	 DJ,	 Chopra	 I.	
1999.	Expression	of	the	Staphylococcus	aureus	UDP-N-acetylmuramoyl-	L-alanyl-D-
glutamate:L-lysine	 ligase	 in	 Escherichia	 coli	 and	 effects	 on	 peptidoglycan	
biosynthesis	and	cell	growth.	J	Bacteriol	181:5909-5914.	
139.	 Basavanna	S,	Chimalapati	S,	Maqbool	A,	Rubbo	B,	Yuste	J,	Wilson	RJ,	Hosie	A,	




140.	 Krismer	 B,	 Liebeke	 M,	 Janek	 D,	 Nega	 M,	 Rautenberg	 M,	 Hornig	 G,	 Unger	 C,	
Weidenmaier	 C,	 Lalk	 M,	 Peschel	 A.	 2014.	 Nutrient	 limitation	 governs	
Staphylococcus	 aureus	metabolism	and	niche	adaptation	 in	 the	human	nose.	PLoS	
Pathog	10:e1003862.	
141.	 Harwood	 CR,	 Baumberg	 S.	 1977.	 Arginine	 hydroxamate-resistant	 mutants	 of	





and	 initial	 characterization	of	AhrC:	 the	regulator	of	arginine	metabolism	genes	 in	
Bacillus	subtilis.	Mol	Microbiol	6:267-275.	
144.	 Shoulders	 MD,	 Raines	 RT.	 2009.	 Collagen	 structure	 and	 stability.	 Annu	 Rev	
Biochem	78:929-958.	
145.	 Bayer	 AS,	 Coulter	 SN,	 Stover	 CK,	 Schwan	WR.	1999.	 Impact	of	 the	high-affinity	
proline	 permease	 gene	 (putP)	 on	 the	 virulence	 of	 Staphylococcus	 aureus	 in	
experimental	endocarditis.	Infect	Immun	67:740-744.	
146.	 Coulter	 SN,	 Schwan	 WR,	 Ng	 EY,	 Langhorne	 MH,	 Ritchie	 HD,	 Westbrock-
Wadman	S,	Hufnagle	WO,	Folger	KR,	Bayer	AS,	Stover	CK.	1998.	Staphylococcus	
aureus	 genetic	 loci	 impacting	 growth	 and	 survival	 in	 multiple	 infection	
environments.	Mol	Microbiol	30:393-404.	
 
